var title_f2_8_2176="Complete transverse vag septum";
var content_f2_8_2176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transverse vaginal septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </p>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2176=[""].join("\n");
var outline_f2_8_2176=null;
var title_f2_8_2177="Glycerol phenylbutyrate: Drug information";
var content_f2_8_2177=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Glycerol phenylbutyrate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F16124885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Urea Cycle Disorder (UCD) Treatment Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16124888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ravicti&trade;: FDA approved February 2013; anticipated availability is April 30, 2013. Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F16132309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM338056.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM338056.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F16124887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Chronic management of children &ge;2 years of age and adults with urea cycle disorders (UCDs) that cannot be managed by dietary protein restriction and/or amino acid supplementation alone",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87892 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-FD20FAF05D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2177=[""].join("\n");
var outline_f2_8_2177=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16124885\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16124888\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16132309\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16124887\">",
"      Use",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87892\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87892|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_8_2178="Elliptical lymph nodes on thyroid ultrasound";
var content_f2_8_2178=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F73138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F73138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Elliptical lymph nodes on thyroid ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A longitudinal image of the left side of the neck that shows several thin, elliptical lymph nodes. One of them (+ --- +) is 1.25 X 0.25 cm. A 14.0 MHz transducer was used to achieve high resolution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2178=[""].join("\n");
var outline_f2_8_2178=null;
var title_f2_8_2179="NAS assessment score sheet";
var content_f2_8_2179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Neonatal abstinence score*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 789px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A score greater than 8 on three consecutive scorings indicates a need for pharmacologic intervention.",
"    <div class=\"footnotes\">",
"     * Based on Finnegan scoring system.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Management of Perinatal Substance Use and Abuse.",
"     <a href=\"file://www.childhealthnetwork.com/\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"      file://www.childhealthnetwork.com/",
"     </a>",
"     . Copyright &copy; 2006 Child Health Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2179=[""].join("\n");
var outline_f2_8_2179=null;
var title_f2_8_2180="X-ray scaphoid fracture oblique view";
var content_f2_8_2180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    X-ray scaphoid fracture oblique view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAkYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3r4nePtL+HWg2+ra1b31xbz3S2ipZojPvKO4JDMoxhD39K8z/AOGpPBf/AECfEn/fiD/49SftocfDDSf+w1F/6Inr4zzQB9m/8NS+C/8AoE+JP/AeD/49Sf8ADU3gv/oE+JP/AAHg/wDj1fGeTTS1AH2b/wANT+Cv+gT4k/8AAeD/AOPUh/ap8Ej/AJhXiT/wHg/+PV8Xk80RI00qovLMcUAfbFv+054QuF3Q6N4lZfXyLcfzmrT034/6Fqd3HbWPh3xLLPJnaojtRnH1nr5H021CIkYHAFe2/A/w/wCdLcavMnyIfKhz3PfFAHuX/Cw59m//AIQzxKF65Mlh/wDJNLB8QbidisXgvxKxHX95YD/25rPu5g0ggjOT6eprStwun2TORmVu3qaAHN47u1Yg+CvEmR1/e2H/AMlUg8e3ZGR4K8Sf9/bD/wCSqp29yzzgyYwTzU6ShpWI5FAE/wDwnd5nH/CFeJf+/th/8lUv/Cc3v/Qk+Jf+/th/8lU5GJ5FSeZjrQBWPjy7Gc+CvEnH/TWw/wDkqq8nxJeMnzPB3iVcdcvY/wDyTV2chkJQfMO1ZTwGXO8Dr0oAkHxPyM/8Ih4k/FrH/wCSarv8W7dJCjeE/EgYdRmy/wDkmqeqWgij4/iHA9K4zcy61IWOY165oA9Kj+JbSAFfB3iU5Gfv2I/9uanT4g3D/d8GeJD/ANtbD/5KrkbK7BQMDkZwfarrXir91/mHFAHRnx7df9CV4k/7+2H/AMlUrePLtRk+CvEg/wC2th/8lVl291JHErFslhkE0k18y5+bJHU0AWrr4mm1XNx4P8SIMZ+/Yn+VzVR/i7bRx+Y/hXxGq+pay/8AkmsbVWaeCaMuQzKfqDXml20iztHM7yDqjE9aAPVJPjto8bYfw34kB6/dtP8A5IqN/j5oiDLeHfEgA/2LX/4/XiuqMPvADg1lzScHtmgD6Ef456QkayN4b8SbG6MBaEf+lFVZ/wBoPw/AhaXw/wCJFUdT5dr/APH68M0q8GyWymHyEZTPasTXjI8cqM3BG0/SgD32f9p3whAVEujeJF3DI/cW5z/5GqIftSeCy2BpPiTP/XCD/wCPV8p6pCZtNEqAloD82PT1rAcHOVPNAH2Z/wANReDP+gR4k/78W/8A8eqSL9p3whK+2PR/EhP/AFxtx/7Wr4xV8jNXLA/6QOeq0AfZ0f7RPhyU/JoPiQ/9s7Yf+16sD4/6Eenh7xJ/3xa//H6+U9LuSoVWOMd637WccDbuXrxQB9FyftA6BHy/h7xIOp+5a/8Ax+poPjxo04Bi8OeJGB6fLaD/ANuK+aryYZWNSNzHAA/hHpXUaYVhgUn2x70AfTngPx5ZeMrrUbe103UrCaxjhlkW9EXzLKZApXy5H7xNnOO1c/d/GTTINRv7SLw/4guPsdzNavLELUIzRSNGxXdODjcpxkCue/Z5ff4l8Weos9PB/wC/l3Xnk8qp4h8RKc/NrWofj/pctAHrZ+N+l8/8Uz4k49rT/wCSKB8btMLbR4Z8SZ69LP8A+SK8hlQlWCLGrE9z2qwECqvmKpHBBHHNAHsEPxftZv8AV+FPEh/GyH/txT2+Ldumd3hTxIMcfesv/kmvMbe7Mb7VIZQCH9QPWj7QFn24LHG7JPSgD0sfF+0LhB4V8Rlm6DNl/wDJNS/8LYizj/hEfE352X/yTXnEBRZmRcBgNy8cgmtCCQZQOSN4PfjNAHdD4pJ/0KPiT/vqx/8AkmhfikjAEeEfEmD/ALVj/wDJNcRDvfHVUB6n1rRiCSN3VdvYdTQB2CfEOd/u+DPEh/7aWH/yTRN8RJoV3SeDfEij/rpYf/JNZ2mynaBg49+1M1s7ow3VQOlAFv8A4WivH/FI+JOmfvWP/wAk0q/E/djHhDxIf+BWP/yTXKMVBjG/HsRVy3DbMnoDnIoA6NfiUzZx4P8AEnBx9+x/+Saa3xMK9fB/iT/vux/+Sax4owTkdhnaDSTpn03d6ANgfE/dJ5Y8H+JC+M43WP8A8k1KvxGlbkeDfEh/7aWP/wAk1xsjFZzKgI2cA+v1qe4v52h+UhQcZC8HHrQB0s3xPELhZPCHiQMewexP8rmmH4qIBk+EfEuPXdZY/wDSmuesbN7h1kONhJ3Emrt5BGbN40A2gd+9AGpF8VElYBPCPiQk/wC1ZD/25qd/iUyDLeDvEgGcffsf/kmuGs2w+9ckoQGPYV0rbZbcbupXB96AND/haA3Ff+EQ8SZBwfmsf/kmkPxRUNg+EPEuf96y/wDkmsBIsnb3PXPU1Kq7jjgE9QaANtfigGPHg/xL0z96x/8Akmmn4poDg+EfEmcZ+9Y//JNYQUqxGcdunFVZ155ODz0oA6WX4rRRQmZ/CPiURjqc2R/9uabbfFmC5IEPhPxIx6/esh/7c1yEc0aM0crExycH/GmW8H2WU/N8ueo7+lAHbt8UQpw3hDxKD/vWX/yTUbfFeJWwfCXiTPpusv8A5JrBbEiK7dG6jPQ+9ZNzCASd4Ctkse+aAO1i+K0UuRH4S8SNt64ay4/8maR/ivEn3/CXiUH62X/yTXBoRAFMThFPcdDV0ETqASMgY560AdaPi3bkZHhPxJj1zZf/ACTUP/C5LLBP/CLeJOP+vP8A+SK4u++aAxqVGB8w9KwZx5XloMvITksKAPSpPjfpcahn8M+JADz0tP8A5IpD8ctKEYc+GvEuw99tp/8AJFeUalHFbo+9Q0mQQgbORWRNc+ZHvbeEz908BR6UAfXHh7VYNe0DTNXs1lS21C1iu4llADqkiBgGAJGcEZwTRWL8J/8Aklng3/sC2X/ohKKAPLf2z/8AkmOk/wDYai/9ET18a4r7L/bO/wCSY6T/ANhqL/0RPXxrmgBpxTGpxNRMaAGtWx4dtN8jTMOnArJjUyOFAya7vSLIQ28ceOccn3oA0dKsJLmeGC3XdPKwRAB3NfUHh2xg8P8Ah60soCNsCBc/3mPU/nXlPwo0Tfef2hKp2oNsRI/M16jNK1zLsT7iEKPegDX0SPzbgyuMlTnmnareCS7Cq3yx8cetWLf/AELT2ckB8fqelYb98nk+3JoAuWjtJKgUcscmrcUAtp2JyxbqSeAar6f8i5Odx6+1XrhhsD+npQBajmfqMYqcyqRhufasgTMo+VjjP4Ukt84TO0UAazYGPL5HpUTlM+mf1rDfUJiSGfAzjApq3abgWbI6Z9DQBpX5idolPzNzgDpXG31oIbud1GA/pXUSSAqCpGB1NZtzCtzA6/x5yh9aAOeRSRNjll+Ybe/rVqzmwr5IAPOSe2KEhCMXIGQCMdeartFtLJGQoI6H1oA1YdSVEMUjMwUY3DoeelXAWk+dWLA8DFcyvDLkN1brWxpM7Abd25T94UAOu3KTcsGx1bPX2rgvFSeRLJtzkHzUPt3rutVjweDmPHAA/Q1yviCH7VZvtwZIR27rigDh7iZZFPOVIrFlcq23r7VdJ4KjrjK/4VnzuN+4dD1oAjR2EyOpwQf0pdbdTaM6EeZj5R61XebEmE5YjHHb3q7FYA/NMQWAzz3P+FAHIwM0UbK2fmyGBHUVz1/B5MrBeYyePavRNYsFkhdgPlAzwOQf8K4G/YsjluuBxnNAGUxKNkdD1q1p8gNwv0IqtLzUUUhikVx2NAHY2zetaEMjAYDMB14NYNjeRui88n1rRSdcZ3D86ANmyHmXkQ6/xGure4WO1jJIC8HmuN0m4BlkZOWA2DHvWzLK08mMnahAVPTFAHu37NTtJ4g8XO3VrWwP/j93XAX+F13xIzE5GsaiQB6fa5a739mbH9ueK8En/RNP7Y/iuq891eQPr/iCHHP9s6ic/wDb3LQBK8qMEaNegyD7+lIzFowT8wPUf3aoh3lt12ERvH1IFXYJBtGAWyMlsUAalgjRrOsrrvCjaPUelKfMHllsLk7dveo7SRmLySKDIi7elE581EkCkSL8wyOtAG1bsDbDCDejYZq0QpZGyoxkFQO1ZljMfs4aQjJ6xitO23gyFhmLHHrQBYRGI2AErn8quI69gcjiq0YJ/jJJ54FTIfn+VBt6CgDUhcKAVzzim37tIpQdfTPWkiC7MEduPrRLbl8Et15AHrQBltGd4Z8DaMc+tW4ZQGjQ55PzCqskzO+yZNiI2CfWmm5QTAId3OOKANl02j91jBHJ/wAab56BRwCx4qjLePzCiEhjy1RB9jrnjjkUASkCSWSPGVPfFWIbWFXX7Q3P92qYnGQ4IUNwKtRyb/v4IHSgDVBUMUGAOwHrUMwLb4yBjHJqWFCwXpx3HUimTxkSO5YgbTQBxjs0U8oU/Lk4wcZ9q6WwuFksY5M4YDla59gqllKZXJOfQ1YsWaJGKZ5Pf0oA12ZA+D97rn0qGScMSuBnGc1XkkLqrKCzA4OKm+xTPGxOFJHegCN5t7blYFs0h6vzj8asx6eu1Tv+bvxiozYzgtyCOwoAyLuFiC6kbgPyFUoLt0GxyGZT8vuK072OS36KWJ6e1Yd6Ms0kJ4HX1zQBvafqUD4jfBDcHcallMbTb1CbWOMVxkd/mXIIV1+9x3qWa8BbKM65/hzQB0JSIK/lx4JOfmPHvUTyqpRVQ+xB6VjR6jM5RXYdcYx2q0rna8cDjzOgDenc0AOa+VgdkOZWbbkng1gT325p3R180ZCgDjPpUl1eMXZACsEQwCO5rHucLIojJwOcA8nPWgCpbzXDZkuSG25I55B9KpTTO0h3ELzwOoqxcRxoGETEMw6sentWazFRtQZPRmPQUAfXnwn/AOSWeDf+wLZf+iEoo+E//JLPBv8A2BbL/wBEJRQB5b+2f/yTHSf+w1F/6Inr41NfZX7Z/wDyTHSf+wzF/wCiJ6+NCaAGMaianuadbxl3z2FAGt4bsjPeAlflj+Y+57V6ToOkyX95FbQjlzyR/Cvc1geGrJbWwV5R+8f529s9B+Veu+ErRdL08TSKBd3AzyPuL2FAHXabHFYWgtIAq4UZx6DtW7pOySdVxzx0NcrZQz3BEiELHnBZu474rs9CtIQwcFmbGCTxQBf1KeJmWFgNvU/hWbcQK3zRtkAc+oqzdRwvcSsQ2SccGqcweIZQ5TH40AWbd9mA3GPWrVzNtt2JPGBk1lfbYnUuuW47VDLdSSxgEYQHgA0AXo5Q4VcYz37U+QkjBGT3HT61lfa1BU56c8mrDXsbx8HcCOT3oAjkOADGOD+tVZWBBGeT1A4qeViiLnklazbiTBJzkDsKANO1vEKmJm2uo5Hr71NE58lWGSQSRz71yN/PmYYJzt7VZ0rVJImMbtuXHANAG9qANyhaH5ZO6j+L/wCvWFdCRolwQrqe/f610VsI7iMTw/f6soNZ2t2x8s3VuCxB+dRQBixTuCFkCnFa+nSpu3DjPGKyZIvMYSpgkfrVyxI68fKR+VAGpfyhXIblHGMehrmbydLaYh/uuMHHpWteypHp01zKfkT5yPcdq5FJftrmafIZhlRjgD/GgDltfsprW+ZYuIWO+F/UViz2g3bmkYg8/T1FehajClzaeS/UDch9D6VyNzDK0fkNtVELFcLg7j1570AZZhRFIjXr196tQTbF2zfN6H2p0agptUc9OaaVGB60AS3DROrEuq/LjI6mvL/EFq9nevGqkwsNytjkivQ32gcnPNZOvWi3EayRgmRO3qKAPOZDx1qKMbpAK0dYhVPmQYOcMR0qjApyCAetAF+CMY4q5EpA6ZqK2wR9a29CtDeanFFjIUFz7YoA1dIh+y26k/eHzN9a0LT5pVcjJwX64qC6Xyzs4I6U60fEhVdpJQgcZ570Ae+/svsX1jxW7NuLWlgfp891XnGrLjxP4jkUEuNZ1DAB7fa5etek/syZ/tjxT0A+x6eAB2w90K8g8Rambfxn4niJIQa1fnj/AK+pKANNXi3BImwsnI9z3FWUCGGRVkKFBytZkDQXKeZA+4jk5q9BOyF5FjUpgEcUAaunSzGN4jjKrjce9TZeG1CSOQ5XCDOe9Z8O4BnjGDuHHr71oFTIyMWUqMgcdaAJbZzFc7QWZivI7V0lnKXVdxyAORXLKJTOHLhkTA3AcZre02dZJFVVwg5Jz+lAGxu2bTgHf07cVbts71Gck/pWfHPHNMSRgr0Jq6nyqu35nY55PQUAXlAVQDySeKsnD8Dt0xVaIEAhjjvmpAx25GRg9j1oAoakjjbgHg8gVSa1VWDRjKk7iw9a6C6jRrbJX519axhIFgbkDdwFoAZJIScxJyR1FVvnmdWIAZT83PaliWTCoV5Xn0p6BRcO+SO34UALK3mbicLt4C/1qzp7x7iSTjb0rOG9550K8L0PTNNh8xNy/rQB2do+4D0Ip16AIcj0xzWPpl7yqyn5z0PatK5kDR5+9QBzM+Q7qI9xzzRGFhOOTx09Ks3x2TK7Kfm6VnyXAjkZUfp13GgDa0aNTA0oXLE9K1XJLgdE96oaSSdPVt2SD29KnMi78DI4z+NAEjKTgqQCDjNRlwp253KT19agmlKMRtOMZY9qje4DKTlA3RaAJZSkjbQoOOpNZ97pttPkGPbk5JXip2lKtlmUP0qvNcRpIyyTLuAzgdKAOA17SbmDUjNYsHQdUPWsia4lR9rBkPcHiuxvZkku3+chh1wODWVfJFcxssqBwOh6EUAYxvAHDq7KRxRLqPzK0Zbcw4BrO1O1lsf3qKZIM43d1+tZjXuMbR0oA3zf7l/ftuf+H2rMvJzG7+XyzelZr3bYOSaryXkhj2gBeOvegB1xdIMbmZnXsP61nXFzLLkFsDOcChyAvTNQMRgZoA+3vhP/AMks8G/9gWy/9EJRR8J/+SWeDf8AsC2X/ohKKAPLf2z/APkmGk/9hmL/ANET18ZMa+zf20P+SYaT/wBhmL/0RPXxgxoAbgscDqa2dLtRvjU8liBVCyh3NuNdJpMQEqmgDt/D1sk92jSjMMRDkH+I9lr0Kyze3GJAAoOTz+lcX4YhMluh6rliff2rvtLtJEidxHncRz1oA34ZwQgCAIOAB0FdBpsu2D5evt3rkI2cLHvxv6c9xXQae5W3UsTt9e5oAW6upxK+JCB1xis24u5ZCRJIdo5x7VoXoDSE9yOT2Fc5qErmfhSyHjOOtAG4rKkUfI5UZ54qG4ufMwsfI9f8KqRytcQhpGAI4xngU4AKcliVHPAoAc9wVBDA4/nSx3sakhVwcdDUUzDAKpn6mq247TgDHfAoA1ZLvzINgOCORnv7VRupsAv045zxiqhDc/M2M55Nc94g1I2NmsczHNwdit6DqaALUl0S7OxAU8YzSW05F1G5PRhx7ViQXKvz8xx2BqyJ+AR19c5xQB6JYSmB89Afyq1duQVkQkL1PNYemXIuNOhf0GGokvTGuCAwJIPtQA0zpHdZ3KFduAD0PpUpJimBjYbWb8qw7uVnmXcoBU5GBWlZ3ZmQKSM8f/roAh8WyG20OGLBPnTgsB/dHNYlq+3aV+73OM1o+PJubGPIwuTjPtXNxyFGIVivqAeKANiT95CgGMDOdxx3zmufvArySFRwxzmrsk7um1mO30qlO47mgDnrlnt7kgZKHkDuKPtUfcHNSXzCSf5eijH41VKdaAEnu0HCqx+gqhPO8itgYXpjPNXWjB+lQSQ45H5UAchrls7QEBNoX5gvrWTAM44Nd9d2qzRe446Vyl3ZPDMcY+lAEdrGNvTknrmuu8Gp5YvJQPm4QHPQdTXL2q8dO+cV0Ph+5EDS2/aYjbk45oA2GVLh5SY8BT94Hk/T2q7Y2MLsCkvXgf1pbKC1iO+/uoIh/ceQDP4V1uhXfhhSnnTwrg5BGcfrQB6N+zhb/Ztd8URhg3+haecj/fu68I8XnHjjxTwD/wATm/4/7eZK+kPg3LYTeL/Er6U6NAdN07JTpu828z/Svm7xd/yPXio9xrN//wClMlAEOj3LWl0ueI34YGunhYL5mwFgBuXn9K40nPbOOwrodMm+6COGXpQB0FlKnkh8/KCePrV6JT9nfaBtJBGD+lZVkMN5YOUIzmtuCJWTYpUj7wyenvQA5EZR5agGNfmIJ5zVqG4EIIx8zgfKBUCFGbcDncfmxVqJTI7Hb8ucl+9AGnYEyKqEA46kVsW0ojUPjGeo9KxbXEaqISxPc+laUJZcBmwMZwR1NAF4b96/Oc5yKuJIVjy69+vvVSMAqhwC3UDoKtJtX5WUsrdVoAdI+IjGWPzDg1kKdshZgGWMfMvrVyePy1dVO7HUGs5pSzZhUbDwwbvQBA5cjzVGd5wMnoKmntyIYnyuOpwadOu63OwgKOCKWNiloVIJI+6fSgCGZQJGdejDJGajU58zacEr9cCpHj+ffMWG/gAdKjRWEmxQQrnJ46D1oAnRhAiFmAYDkHvVo3DmDcjbs8c1TnP7wKGDEfdzzSlmMWcY5wwHagCO6vJFBV1/+tWE2qAXQt2ifcepPeteR1I+fHmdAKqx2YuJfN2BHj+764oA6HSNQYqEwArDHHap55ZTN8x4wRxxWNaMqDcT901quxzG6nhuTzQBFcOXRwSwBA6GqN9M7S5UZCqB7D3q7dIZERo2wD39fasq8RZk2x7gob5ytADvtJRoVUqyAFmb3qg9wN7zTHJJyPUCpJTvt9iYBY7d5HYVSubqKGCd2ZdkSEn6DqT7UAYPinxcmj6hDbxWJuRJEJJPLYBkDNtQKD94khuMjpWtdFXs4/PzvzwOma860Uv4g8TNezqdu4XTL/d/hgX8AN31X3rvb8/6QqSEMI1wc+vpWVKbmnLpfQ7sdh4YZwpL4rJy9Xrb5JpPzuJJEvKkErIMlW5/yK5nV9CAZ2snww5MRH8jW+XIlknc5TAKqOwqCScIWY4B4LEdD7VqcJwTk4IcFSOCO4NQyNtAxzW/r8Akha5CqsgPzqvcetc7IeAc0ARv3yMGoXA68Yp7n169qiYnAHegD7h+E/8AySzwb/2BbL/0QlFHwn/5JZ4N/wCwLZf+iEooA8s/bQ/5JfpP/YZi/wDRE9fGSrvkC9q+zf20f+SX6T/2GYv/AERPXxvZrumJ9KANK0jwBW3pwCuCeKy4AABXXeGrKNQlxcIHc/MiHoo9TQB0Phf7W1uUghcqrbhnjINd7oM13FOUdThgCFDZ4FcpaTMsoZcsemR0x6V0+kahD9sjMn7s5Az9aAOvTyJoxuwJO/HSplOIJSBwBnnsfWomNuy8um5RkHdWNqeolwbeFmIzl2A447CgC9BcNNNl87AQF7duc0t/5bRLtwAMrisK3uZc4JJYdATgVf3koQT+GeKAIbGVfOaMfKHOV4x061odAcgdcDJrmtXna01SEq3MQDH6nrXSsVlSORSCjAHgUAQTuQrHcAD0I9KqM+eMnjt70+Xnk++fb0qqzlQR/EKALcQDxsRxz0+tcB8Rn3anZwj7qRs5Hua7yxlVuEHGOfavP/HYz4hwP4IwBQBj2l48ICtllHQ+la1tfCRRtOR6CufPAxTVz1BI+lAHpng6+8z7Rasf9oc+talySpIyK838MX0ttrlr8/yuTGc+9d3rksqyxAYVSCxPtQBC8m1iCRgckmksJC91G0eRtyuMdR1rLilkYMXJYHnHoK19HXbcRNwdxORQBm+M71H1KGMthgMYrKWReuaXx2n/ABNoWxwVNc+rOB8rMB6E0AdBJOuMg8D3rMurvcCsXJ7t6VUBZvvMST705UwQP0oAYi+34UuypVXr707HvQBX2Co/K6/1q4EPNGz9KAM5o9p45FZWq2gYCRQc5wa6CWPI7fhSWNusl7GkhwCDj8qAOVh00sSzLs5xSy2xjYA/MD2A5rrPsm27aMck9M+tLFpoScnG6Q87scD6UAYWm6C92+ZHS3X1blq6W38IaaVBaS8lP97hRmum0zRwFXcnyEc56sD3Jrq7PTwYlCKMcgUAbH7NmmQ6T4g8WW9s0jRtaae/7zqMvdj+leDeMT/xXnir1/tq/wD/AEpkr6U+DcYi8aeKlXp9g07j0/eXlfM/jQgePvFX/Yavs/8AgTJQBUU8/XrWpZORCW7j0rIiPQ8+1a2iWkt5dMEGIl5c0AdPpET3ciGEfKByT0rq7LTVUNum3Mwwox0rGspIkaOKIBdowF/rXR2EpcEn5QAOCP5UARXOnSWyqEU7FGdyjv7VPbwF8Pn90o5XpzW5DKMZkI+T1/wp81ql0o8olWBzkDhqAKFqiKg2AZzkk1ai3K8ahSw68+lRxRSK7rLHjb2HerMQVo9pO4ZwQOv50AWVChmA/h5GPSrAyVBXG88A/wCNU1UiNRHhmPv0q7Fg7QynGOT6GgCOVSyvj7rDBrnmEqT4UqQDyScZFdFLuLYzw3Qf0rnruIvcSDftKngetAFu3lDfKQAp4IqWWRzbutuu7bxz1rNZlVcdx0Oe9XIJnSycBwZByBQAiuHlWM5B2ckdBSW0g+3KWU+XsIVwc4NMVVedHIZZNuGA6Go7Vdglc8kcfKelAF0pFEfMYEEDIbtmqiSyjc8oypGF9/enRMZfMjlyVVsgY6inMqpGWmY5PQDoKAIYYySeD1yC39KuwRqAG2ENnFRRJ54Jz8gPIHXNWzx935WxxQBQni2XTxgAbuc1owuGhDEDGMKM96p6gFCRAkl2+XpUtqFCMuSStAEo+4uVwBnI9KoHEYA2ldxycVaUttdmzuByAagvmIMe8AOPmwaAMaRpvtEm35o8kAVxXxC1CG3sxp8TlXugRODxthXlz9Dwv/Aq7SYsC6k4B/iz0NeW3LL4k8ZbJGzaNJ5ZYdPIiPzn/gbnb7gisa0mo8sd3p/XoehllKEq3taqvCC5n522Xzdl8zrfA+leVoiySoVurk/a5M8EZHyJ+ChfxzWrJGrRvdNzLIdoqxdzCVwit5argE+1OYKiopB8tTjgc1rGKilFdDjrVZ1qkqs3dyd36szfs4WDa+SWYj6CqF3CxGYQCm7HzHGR61sMWxMETdx19BWVexefHgZWPGAMcmmZmBqW2CzuyzblI2gkVyJGF/nXQeK5BGIraN9y9TXOscAAjigBjfSoZD82amxnPrUMh7A8UAfcvwn/AOSWeDf+wLZf+iEoo+E//JLPBv8A2BbL/wBEJRQB5Z+2l/yS7Sf+wzF/6Inr45sP9Y1fY37aX/JLtK/7DMX/AKInr42sTiY+4oA3rRPNeNB/EQK7XTZAXJHCf4Vw9s+3YynkEV6Hp6x2yFvlO0japGfegDfsIiUQsCjHCjn8s1pGNlU4GcKT9MdqxbW5KlihPzHJyQcY7j3rZhuA8ewbQ2OdvuetAG7pdx9otgW+/HwehOKh1AhZQ4PykYbHUVS0yZLa+Vn5jc7DjgDNa92FgdUYBgRkd+KAKETqOVYnnuK1rZ920Hlhj8qxQMOdhwvUVraWPMniB6npQBh6/wA61crnIUKB+Vb/AIcm8/SApPzRnaRXPeIiE1y8PA5H8qseDr5ftdzbBt+4BhQBszrtLcAc9TWRdzFmZY2wM8n/AArTv1dyyt0J6Cs548MMDGDQBf0BB9oO3GCvr1rhPG648SXIx0VcV6D4eQi5GcEjOa4j4gR7fEDHHDxA9fQ0AcpJ1I6nNNAHSlxlie3alIwR0FAElmxS/tXHBWZT+teoa0o+xwy9SAV/OvLUOJ4mzwHU/rXq90BLooPZSDQBzKKUcFQdoY9uDW5ouGmjznIyB6VlxBkYFTjB6VvaIAZlOMcdugNAHJePV/4mcHHqK5tVH5V1fj1D9rhPPLEfpXM45oAYB7U9VHUfpTgvI65p4Q5oAQLmnBMc4FSxLuNSBefegCLZnkUFeOnNWAgpSgoApNGdvpj2qFkwwK5DA8EVoMvp09zVeRMdvyNAFaS/mE0eVXcPlDdMmt3Tg06qyjdM45z0H1/GubuY85xxXTeHN0tiJB80j5jH+8OaAOospVit9pl37WCkjnkjk/nWwl7x8g3Y+VR07c1zkChYxAoKhMNtHeTqQfap/OW3VfPzvcEcjpnqcUAej/BmTzfGXilgcj+z9Ox7fvLyvmTxu2PH/irnH/E6vu3/AE8yV9IfAeQSeKvFZU5VbLT1B9f3l3Xzd4548feKj1B1m+/9KZKAKkeSVA5+ldhpqJb6bFbJkOy+fI4H5A1yenx5dcrkk549K6yZ5LmFUiUrnCEjgkjtQBpWEYlvd+XaQDJXpxjrW5Z3Eot0OcZfaVJ+6PWs2yij8neu55pCFIPUe2e9a6BYmaRh+8RQFVhwB3oA3NNvA6uQQWBxtHf3NbaTKRycN7DoK56KOR4oyAqr3K8Vct5mhVVdWfnkjtQB0DRfaFCggEYOT3qrtMcpGNq7iDj+dS2tykkuNwRv4Q1WbxA6iRWGcYOKAKCBI0whJJPX0FSpISPlbj39KrSy7cgD5VwDUcMm0ygHocgHrQBdnlyhLYBAyKxJJM3LB8Z61buG3JgZ7EkdzVJI0lcuAd/tQA+NEkkBAK8kgGgFoVPmDkH5z3qf5kKAqpPp61HKd7NIy4XI3L6+1ABhMb1yj4wh65zT13Btm0dPmboM+tKQWlQ4wudw9vakzIUODuJJY0APhZFYHDBmOKSQxMzo+Tn9KdDExgPVTnKn0psdvL5hdgCw6/SgCeIR7GUAq/HA71IdueXwB261DDbuDk58sD5afHHu5Z8qegx1oAr6jLkIANxzkUtskid/m6k56U+7jzLEqqT3xU8MLZYPgDrxQBX2sud5LFu3fFNkAbzfMBLMOAR2q9sRTz98jOfSuW8a682hJp07W7Sx3F39nkweQvlu+V9/kHFJtRV2XTpyqTUIK7eiXmyh46vhpXhiZocC7uGFvAcdHbPP/AQGb/gNcp4B0TGlS6gFwJyIoFPGIU4B/E7j9NtVPGupDxR4ktLDSZd1uu2CJ06eZIA0j/8AAIx+B3CvRoltraxit4EWOCJBGgHRVUYArGPv1HLotPn1/r1PSrJ4XBxo/aqPmf8AhV1FfN3f/gJUaFvLIOdoxuA6YqK7c3KCOBXA+79TVvTZ1ZnE25UcYGeh96v2drAvLSggc5JxmtzyjNZGiiaF1JYKCwHcVzmryvaBmnJG8bjnt6Yrp9Z1uysIZZ1QyyAEkAenvXk2s6tc6rcNNcEKp5CDpj0oAz7yYz3TyMx9qqP9asOABggZPIqs5xQAx2IA449qizjtTpCSQO1MbI4NAH3R8J/+SWeDf+wLZf8AohKKPhP/AMks8G/9gWy/9EJRQB5Z+2l/yS/Sf+wzF/6Inr4ytzidfyr7N/bR/wCSX6T/ANhqL/0RPXxgDiRT70Abto+0q390g13Vo4dVYcqwBHPWvPrZuQK7fw1IbjTGRSPMt25+h6GgDahlbepGPyxg1sWDnAOdyA8n0rBhyMlRwp5Jre03KgL1/kQaANjAkXIByOeB0IrZhnW/0+K5TuNorIRiml3MpOWVTz65pvgi4WXTZbUnJQ5X+dAFxlCrx/kVd0u423kAzkl8YFUirPlW4wOlSWKCO8iYZJVhn2oAyvFsbt4huNxyjKrAfhUPh9vs2sQMcBXJQ/jWx42g2avBKOkke38jWGMoRIvBQhh+dAHod1ACQ3qBxWTInJyozyBW9EPPsY3B44P4Gsu6j5P1oAZon7vUIx2YEVyvxMi26nbOBy6sucV12mjF3GO2awvidAf9Dl6fOVz6cUAecbAMDB460rr/ACqw6YamFM0AQMOM/jXrGlEXOhMvUlM15YV6jGc16Z4KfztHiBP8GDQBnhCpG7PTvW7ocZEgI/T6VRnRgxUAYHUEVr6MB5h2jAC9KAOS8fR5eIj/AJ6dfwrlQvArtvH8fyIemJB/KuQCmgCNV5qQJmnonvUm00ANC+nSpAuev3aUIepFTBemQPYUARbRgZAowcEkVKV680MMLmgCs4wOlQuOmevtVphUD9PSgDPnQc+ldh4BtPM0VH9J3YE+nSuTuuI2bHQZr0rwnai18KQ7zsDR7mPfnmgBt0YobaRiMtg8A9R1rCLmTzJ2O6QtuJPrjGKt3s7SzSMBwTwPT0qsrLtO052cE9yfagD0v4AqE8S+KEXGFsNOA/7+XlfOHjnnx94rGeP7avs/+BMlfR3wAx/wk/ioA5/0HT+f+B3dfN/jr/kfvFeOo1q+/wDSmSgCbSyFu0JO1Rit+CXa0hj6o2dxPQmsTRdssiAHk84H610kMMZZCiAq3Jwe/YGgDY0uQqVUHcHwQT29TW8I2klBjkzE4+bdzmuWsmMS+ac+a6kFew54re02QBUyrF+5Hp60AdL5Ue1YwreWgBAPrUhiETnLnDY+QDioLOUSAbnD4G35fWtRWQxKrqQwPpQBWWNWkGAVfPy+/tVqSPgqrsp29SafHbkkMo9wT0zTpEymXPzg8ntQBgakZ1+aJ8DHzhu/0rOtb9xOCZC6t129q3bqNcOik5JzuI4x7VQmsVifcke1X6mgCeQt9mYqeGPy+9Ee5c5A246DtVaObymjgY5Ue/ArWgjyfkAweaAHRgOcZ+cjJOOntUZwqDeQxzxirPlqFJyCxH5VXYGMgZ3HOcf4UAJMC5JZhtYgYHanAKUUkkEdPXFQqc71PGMnHrT4yxVGGRjHB7igC5bLmP5jjncKnYgZYDKnggmpYVCJ94exxyadIw3joD34oAhcIFAPB9KjR1VFL4CjJP1pz4V2ywyBnnvWRPdNMwXYREDQBa3vI/DqM/niraEhFUEHI4PrXNxXf2a/xMSUY8nsK15LtGRWiYeUvU+9AE8kmAS+Pw7e1ed/Fdg9hpanJK3+c54/1MorsJL3DpklmY5xXHfEWK41G10+302ITTi+DHsqDypBuY9gMj/9dZV4uVOUVu0zvyqtChjaNWo7RjKLfonc4S2Sd9Qgj05XN+24R+W5QgH7zFh0Xpk/hySAe8020n0/T0hurqa7uS5aWSRyw+igngUuk6NBodu0YPnXEoDzXOOXx2x2A5wP5kk1JqtxIiRRRL8zc5HO0VlhMN7CFm7s9DiDOVmuI54QUYrbRXfm3+myJbSUSDyXJyx5PoPStF9u8RlSu0Y59Ky0mWPZJtzL3PapdS1FYbV7l2OEGP8Ae9MV1HgHN+MLyOGNrSM5kkOWx2Fcc/GQP1q3dTyXNw88py7Gqsg5oArPweB+NV35f2qSRssQPWoHQ4yTmgCI8PRJg8jJ9qa2ARkc0EehoA+6vhP/AMks8G/9gWy/9EJRR8J/+SWeDf8AsC2X/ohKKAPLP20f+SX6T/2GYv8A0RPXxe3SvtH9tD/kl+k/9hmL/wBET18XsKANG2bKqc9q6rwhdC31qAP/AKm4HlOPr0rkLFsxj24rVtJGUK6/fQhh9RQB6VLCYZSu0fextPpWjZMSwwOemaZMy3dna3igETRqWPoRUls/ToFJzgcY96AN5oy2lXQbnI6VkeDZhBqqqeki4+hFdFAvmaVIwHOMVxlrIbS8jkBI8qT+vNAHoGoR7Lgtj5XG4GoEQF+Pr061qSgXNkpXlgMg1nwZ380AS+NbfzLC1uVH+rYZ+hH+Ncsig8EZB4ru76IXnh+WMDLBDj6jkVw8ZO1SCRxQB3vhV/O0uNW5YDac+1NuofmOMcHmqXgyc5miY5wwb8629Qj2yngYPNAGZYri7TPrVT4kW+/SFfB/dyKa0I0AdSOuam8Ywef4eugoz+73DHtQB446AE8fjTNnHt61cMeSCe/NRtHQBUZeR6dzXd/D+T/QdndXIriXX5ffvXV+AJNs08fuCKAOivYClwTnAzWjpA+bOelQamv70OOuO3epdFH70DtQBiePI/8AQ2OOAymuKC5zXofjmHdp8p9Fz+VcAg6npmgBoGealjXuacFyenTpmnhcUAAHFKBjBFOxzSDjr/8AqoACtMfIHb/GnDPuAKa/6UAQtx1qF8euamf681A56/yoAjFubq4gt1BLSyBfw716nqara6VHACAAoJHsOAK43wHYG81wzv8A6u3HX/aP/wBat7xJeebdtGhIRen4UAYs7MScj73PA6VEi7H9alQDDYIB9+lIiNJKSABj+H0HrQB6X8AefE3iliACbHTyQP8ArpeV82+Oj/xcHxYP+o1ff+lElfSvwGXb4q8VYBwbHTyPf95d180ePTj4geLP+w1ff+lMlAD/AApdLb6xAsuBGxIye2a7yySKSV4jgsjbyQc5PpXlUTlHWQfeU5Fdt4evWe7ikiICSH94SeRxQB101vti6EEHJP16CkiL2kaht4kbgd6mguwwZXdTsxtGP880sjgtvffkHt2oA0tPkMYZANhYZK57Vr2164EZkOTjH4etcsGQXIOMMx65zmtVHeZkZRnb8rKO4oA6iyuVkDlWbaeAMfrVuZiyBSM9Oe5rASV1kSJSCBzkCrKzu5OTuXv2FAF3YCdoYAdgeTVfUG8uE7TkmlEigr5WM9OnQe1VNUdi6xop2gckUAZ2wuxk259q0LOdrcbWOU757U6CDYgXAJYZ5oePBJ+Y9qANBJkmT923PpjrVW9D+VmP74HSq4iLEMWKnpkVOzzInI3eme9AFYuSB6n1qaJWknUknA4+tVLm4mHzLEpwORUMV/cPPCFUIN3NAHXqvy8kgKOSarz3CEnad2PQU0qxX5myD6mmeV+9VVGGX9RQBUuPMkfDNtTqB6U21hJb7u1hwCx61pC23kjqAe9VJostknAPTnrigCvPDb3KHzU+VvkYYxz61nSW0cA2IzqingA9verJLMZSzssZI4Pb2prdGZ/mB/h70AVJ41O3a3APJ7n2rPvIzHI5AYMecdquoX2OzjLnhcdAKGcSWzmU4lXr9PSgDIkk8pGVTkycYJ6CokGIwAp3Z4PXHrV+5tEliRYcux7AdDVyPTJVgiDYOfve1AGcI0jbc6g8cHPSsLXp/tO2GJMRIfmB6E10OqRhSkGQcD5jWXNZLIwI+4Ov1oA4y8tfkMkSkkdfpWU53A967G5geKQooBjzgMa5zVrXymaWNTsJwR0waAMYrgHnmo2IzgZNTyDB6frVdxgkmgCvPww6UjdM44pZuo4prHjrxQB91fCf/klng3/sC2X/AKISij4T/wDJLPBv/YFsv/RCUUAeW/tof8kv0n/sMxf+iJ6+L2619oftof8AJMNJ/wCwzF/6Inr4wagCexbkitazODg1jWZxMfcVr2x+YUAeo+CJftnhl7Zj+8gYgZ9Ov8jV6EfvCQcDuBXNfDi7EOrS27H5Jk3AepHBrrXi8m7kU8BSR+FAHS6C4lsp4sfd5ArjdRi8rUJ4yOCcg/Wup8PyCO6UHpIpU/0rK8XWxivIpx0JKn29KAOp8KXX2rS4g3ULsb6ipWjCSEgdDXO+C7sRzywk8H5wP511l4gyHBxkUAWtLYbJUJznnmuNuofs1/cQY4Vjt+h5rq7CQpKpOAO9ZXim38u+jnXGHG1vqOlAEfhqUwaugJ4kUr/Wu3vFLRK4AP1rzu1m8m6hkzgo4NekJ+9s/lIPHFAGUq856CtG9iE+nFP7yFaqMuDx681oRHfa7e4FAHjfk7N0bdVJX8jUUkXUdTW7rdr5OrXSjoW3j8azZE4oAy5YzzxWz4MOzVXT+8gP61QkQBqt+HD5esw8/eBAoA9BvEzGDjtTNHGLhATwKtTDNqpxnmobEDz1xxQA3xfDv02b6H+VeZwrlAa9d16Ey6fMAASVryWIfIPUcdKAJAv6U4DjpSAYGe1OOcYoASkI/ClB/wAKb0BzQAhxx1+tNfnrSnPbPNR549hQBE5P41XmbAzyTwAPep3657itTwjph1HVhI4/0a2+ZiehbsKAOr0W2GieGxvOLicbm9cnrWJNKXJJIOfUdq09dvPtEuFx5acL7ViSsDKQ2RkdR2oAcio+Dngnp61NYxNJcfOCAzfN7Cqw+ZwFwcj9K1kZbG0knmwERNxPqf8A9VAHoXwVdW8YeKVQ/wCr0/TlI9D5l4f5EV8vePT/AMXC8Wev9s33/pRJXvf7LF7JqPiHxzeS5zMliwHoN1zgflXgXj7j4heLMf8AQavv/SiSgDJQ8+ta2gT+TqMYYnYeTWPHxVuJiJ4mHXcMUAek27pJb7kG1gT3yR+FX7S5Bt1R/vZyST1Fc1bTneezqeMVowyqyMJCFTsR0zQBsS+cbiJkEYUc5B5FWbOYwyzPMWJXgKT1zWOz/K7o5kxjC9OPUVbBVYVjL7Wc5Ut0J96ANW31CZihG5WU/QU4XlzJMU3fJjIANYzGSOFUmcSYOVK9zV/TUku49znZjv0yKAOi027dn2u2RtzRHe+bcFmJCg81ktdKoWKDcATtLAcmpoWYoGCAKrYxnqKAOmjeNQMjdkZHPar8IgYBdoyeSRXLvdol1kY+SPJXHSr1lqCiLfKSSxwD60AdE1rE2OxAz04qN7Hcg24z2OetRwX0b7QWG0+9XIZUdV3DGe3tQBkzWLhgAhKnqaz5NMkjdWiTK7ufauo3jLYJB9KC4Hy4AUc570AVlhYr8wxnA6d6lCgcsDx+hq9IcxAjGQOgqrJKicjgn0oArTYVBg4/HvVWVA/HdQcn/CrEoZzkED1NMKBEYnnHJ+tAGGy4YqxywNViSXYoSoBwQe9SSsTPJJnBk4xUTCQuoKgEjg9gaAImJViqZb6VA0DXLHYdoGN/NXI7NnKySbwyH+HvWtDZKuJNuMnoKAKljZrEFAGcHO89TUupTrbwvtH7x/uirlw0duhJJB9PU1gyubmUkZBbv2HtQBlkMoJY5YnlsZ5qC5MisAu0nOOOgrVeMxJucAFepbvWfMqlmKBSpxuOelAGTewDC71O4nbtz+tYt5bqUeJz8zZH/wBeuhuJS6bpgVOTtwOKzLyIMWb+ID/JoA4CRSsjxkYKnGTUMgHbmtTXYTDdq/8ADIKy5ODQBXmzxUMuMDFTydcVDJ06e1AH3X8J/wDklng3/sC2X/ohKKPhP/ySzwb/ANgWy/8ARCUUAeW/tof8kw0n/sMxf+iJ6+MGr7P/AG0P+SYaT/2GYv8A0RPXxi1ACQnE61swHpzWIPldT71swHgYoA39Dufsup2s4ONrjP0Ner34EkMVwnOVwxrxqA5OPbivXfDNz9v0RAxy2z9aAL2mSYZGBwVOa1vE1p9qsnCjkjcv16iuftTtlI4zjpXWxMLjTlJ5KjBoA4PR7jyL2CXOBu2sPrxXpKMJrTPUgZrzrXLM2l6SoxFLyPY9xXZ+Grn7TYxk9duCPegC2pxj/OKl1eL7Zo7FRl1GR9RUcq7Wx6etWbBgwkjI6jIoA5BG3qfcV6P4ek+0afA395ADXn15B9lvpYugzuH0Ndf4LmzY7M8oxFAGnOhDN6ZxipbMjzNpzyPWpbtRkngZqtCds6H0NAHJ+NLfy9QhlAwHUqT7iuedMg13vje032HmKOY2Dfh3riGUEHPFAGdInOQDT9NGzVLVv9sD86nkTLHPfpTIBtu4D6SL/OgD0kLm1x6cg1WhU+cCfrV9Bi0z3A5qqgw3vQBqXSCS2x2Irx6RDFPKh/hkZTx717Mo3WykA9K8n1+HyNcvUOR8+8fQigCgO1KD0PA7UH8elJn1oACc9DTT2NK3WmEjHNADWPGajJ9BSuT+JpFVpZEiiQvK5wFHegAigkuZ0gt13SyHAHp713cUUWj6XHZQH52GZH9T3qpplnHo8OWw17IOW67R6CobubdJmXnOc/U0AVp23OM8A8HIqm4OWwcj1qTztxUZ4yTnHSmgebuKYyeg9PegCxpsInmAIzk8/wBaxviVqhitI7CJvmmPzY/uiumtitnp0sznoCqk+nc15Dr9+2o6jPck/ITtjH+yKAPcv2RDnUfGOOnlWH/oVzXhvj//AJKB4sGP+Y1ff+lEle4fsgnOoeMf+uVh/O5rw/x//wAlC8Wf9hm+/wDSiSgDGQ4IqdD91vQ1AvXBqVe49RQB1lpJlAzEDb94n0rRt3aSRY227B2HFc9pFwHRVY/d+VvpW1A6RuC2QpHU9TQBppKWuQwUgdMDsKt3MkLy7X/eRhfl56VmQyhoRgnrjjqRTxKoA3ICGOGz1oAvl1aNW34GOM/zrQtpnMSIAeDnaK59HE98kSnCdcelbyK+Cx2hB0IPJ9qALcEqlwFYpk8EDOPrV2yd98xmj4jOAWPFU7WUJjaBuY/MQOtX3DqhgyCzcDPQUAEjyFZHiQbWABPfNXLWPcwViCRg8dqojzAypHyq8H0JrShcD54wNx4b3oAk3gTKkYxtPBqQ3k0cnyzfLnAHeq9xIZNvykH2GABSEIHTylyRzuNAGmuoS5KnDKOPepJbycPw6sMZIrK+1GMNuVdp9uc1ZiSWbyiqHDDqKAN21u/NtEIyGHBFPRWePBPzHkEdqi0y1W3Decx2nse1a0cKADywD9KAKUcLHAz8p/M1FeKVidVPPYmtpUIXGMD3FUbtN6gY79KAOa8ncFjcZPUVOLVXVCykFeOK0hCoLFk6cj/61KVXBAwM8gHtQBBDDlsnhAOPekuZo7WJt7cHoBSXN2I0IUfMOABWVslmzJL8/qBQBBdObmUtKxCdgO1Sxx4iwo4qxbwLIoUocg9auXKrFHtXjA9KAMC+O75SpIXofWsiRWiyoVQGPc81q6gXmUMu4ZOOB2qnckQKqugLvzg9aAMeeaWQsWZMJxtA+6KypHaLzZHbIk+VSK0rzFsZJJocb4zgA8n3rLm2GGEmM+XHzgHnHvQBk65Gs1thsBwMr71yjE9COR1rsdUJZgyx4BTPXoPSuUvU8udhng8igChNnfjvUbnt1PpUsg+fjoKhbB6UAfdnwn/5JZ4N/wCwLZf+iEoo+E//ACSzwb/2BbL/ANEJRQB5b+2h/wAkw0n/ALDMX/oievjJq+zf2z/+SYaT/wBhmL/0RPXxkaAI2rVs23RAjrispq0dLbKY9DigDWtj8y5r0DwBeYEtuW6HcB7GvPIDzg10fhu6+y6pA5OFY7D+NAHpNxHtusgfK2T+NdDpEg2up5BFYsv720WRRkp1FWbCUxpweRzQBe1bTUvIXhk4Y8q3oayfC0ktpeT2Vwu2RDnB/mPaulkxLHuB+YCq01kt3LDOmI7qL5Qx4yPQ+1AF26+8G7MKjtpfLlDZ9zinzbjbfMpDofmB7VSjkwcfrQAviW2EkUV2n8PX6Gp/Bk+2a4jJ64ardtsubV4nO5SOhrL0WJ7DXDE2drKQpP1oA7q4G5VPbFUycNVlm3Re+KqHjJagDQvoRfaY6dd6FT+VeYshUEPwVJUj6V6fp0oIMbcCuK8U2RstXmwuIp/3ifXuKAOedeeajVcTRY/vr/OrMo4Bxgj0otlD3duABlpFHP1oA9E6WmOMmqygFuOatyDEYXHaqXRgMd+aANm25jx7cV5949tTFqcM44EqFSfUjpXb2MpIKgnIPFZXjmxN3o7SwjLxfOPw6/pQB5tnJPFI2A3cCg4b5hyMU0nJoAGPTpkVGT14pWPHAqMnsATnp3OaAEbJYKqlmJwAOprqNIsl0q3M82HvpBhfSMHt9aqaNYC3/fSr++Iwue3t/jVqZiWAw3Xr/ePegB5fhnZjljwPaqMsmdwyxUDJGMZpbgswI52Drz96qszM+/PD5GB9fSgB7DgY+QHqMf0qaCPcyL1YnA4qusgWP5my2eCO5rStStvDJcSkARgtk+lAGF8QdU+z2kdhC2HYYOOy968znOOnQVq61ftf3090+TvJ2+y9qw525PNAH0N+x6c33jI/9MrH+dzXiPj/AB/wsHxZ7a1ff+lEle1fsbNuvPGZ/wCmdiP1ua8U8f8A/JQvFv8A2Gr7/wBKJKAMZTip1PHI/Kqynp3qxGSQDQBYtZWgcMvJz09q6Cxv1k2gMAwP8Vc4Dj8e2KsKckeooA6Z55dyY98nHQUx7hUj2oTtzxzmsRZplxiRsVMszlducL3oA3/D+bjWdnouSa6toQJWQgiMEYPv/WuU8EgHWip/iQ4rrr7eZAkbbRuABA6UAWbZjHdGJF5xkH096tOWKDzM5bkv61Xs12IXWTcCMDjOfWrUTLLAN8hLZ2qF7e1ACxL5Cq64+7gH1+tToHcpHkjJy/0qK3bYZBxgDjPOafalhHvO4u2enegBbqaRbgxox24Bwop80nluVXrkDH9aILbbceeGLZG0VpWlgjuJWYbwccjrQA22tFuFQzAlCfTrW58sSxoi4UD5QBSwRRplFFWliwuMD3oAh2uVXcfer1q7IFPUH1qIgbiAe3pSoRtXI4oAuS3SImW6Vkz30TOWB6dMd6dqRZotsfBI7VREXyjA3ZGaAJGuyy5K859aql5XfO5gOg46VaEPyLgZJ65qSKDedoVs9qAKnkbmAJPPQ1aitgu3A47n1q2luiAmT73oKjuLtYVBK/L3zQBFtEajaAOfpWRfXYWQltxAyAOxp99egTOiksBg49KytTkd48xE5zgNigCpfyzrCxaTYHxtYdh6VTu7gW1rGqP5kx5JYc4qa7jZwEkJwoBO3nNVNWSDFuVJxx8p6mgChqpD3aIAzeYowxOM+1Z7rKJ51AG0JjB7GtG7kJuFiZQGJxu9PTFZzI0V/s8wl5RyeuMUAZV+WUsCCUWPaT3rA1aIbEKnLKOT7V093uRmkbkSDAHsKwbyMPDPuUjA4zQBgSnIJ6GoCMDP+TU7YKA5qA4AoA+7PhP/AMks8G/9gWy/9EJRR8J/+SWeDf8AsC2X/ohKKAPLf2z/APkmOk/9hqL/ANET18Zmvsz9s/8A5JhpP/Yai/8ARE9fGZoAY1WNNbEpH41Xalt2KTqfwoA34z81aVu5GCpww5H1rLjbIU+taFu3SgD1rw7eC6sY3zkMoyB+taEGEJTHGeBXF+BLza72xP3TuX6H/wCvXX3ZKTKUJAOAaAN6ymDr8w+bPrVllYHch+YDIx/KufjuisYw2DwOelatveGTow3jggd6AOhaEX2niQYjn2456GudkBhmKSKQQOQa6TR5QbMBuDkjFJqlhFcICWA44butAGHplxsfBPBxWuLZZ7hZE4defesZ7CS1myhDEnoe1bOgzbmIYYYcYNAGohPk46EZzUDPuGTwM45rQljBG9Dj8OvtWMzNllLBhnNAF60kAbcO1WtbtYtR08GRc7e/f61nQb/XtWvaMCmxsGNhjBoA841K1e1m2Sc+jetO0SAz6zZxjrv3H6Cuk8S2aSwsBxLGcqcdR6Vn+Cow1/PIV5RQPzoA6uWIksBzgZrOWL5gDn3x61emnZWkCryEwOe1UJ51jOEzluvPegCxG6xnarDdwc1M0kb22wjKsDwe3rWYJwGABUZB+9Q0+0kHqBxigDgNdsDp9/IoBMTElD/SsuQ4A7V3GvQrdQsrgE9fcVw9zEYXZXHK9/WgBpPoPYCt7TtMaKPzXBa4xnBHCj0+tRaDY73FzKuSOY1Pb3roj5gUGMHjsOc0AZqnBJbI2jH/ANaonYICyjJPQHtWhMyybQ0eDj5sdB7VRurcn5o+T1K0AZ8rEO4QYIGB9ajjdlAJbcyYHHUk1Iy4XaRs5xjNR5wCScDtj+dACoSJvmAMoHGBwPWs/wAZaibfR47VG/ezt859B3q4ZAF3NyOpI7muN8XXZn1EZPEcYAA7ZoAwZm6+1ZtzJwatzN6nmsu5f5iM8DrQB9I/sZf8fPjP/csf53NeK/ED/kofi0/9Rm+/9KJK9m/YscPceNcdlsR+txXjHxCP/Fw/Fn/YZvv/AEokoAxUOasRk5A/WqycdeBU8f50AWFyTjNSxE55zmoUIGBipF69aALKnnntUsZ4yKgQDAFTpgZIPBoA0dKvDp+ow3IyQDhvoa9GQrcx+bE4KEZ+teXAA4zyK2dG1SSwOw5eA9s9PpQB3VusqQsEPz5+VRVq0DLuWNDxyx9aoaRdxX86GByR1bHauijeNEKbR6cdaAKiwMUy+PMfgj09qvxWxVlV93IAGOlWoYkkZT79D1q/FAka8Z254oAigtAZAFGMdiPzq8iRxnoT0HTpSxgfIcAepz2q3axgk5yfr3oAmiiyCQBhuvGKkdNwwMEg9ac+1FGcYHrUcsgX5V5460AKyfOd+AKinuFSMCP5iOMAVWkLTsCwPBwcU3yZmyoUKAeaAGNI7F+Dk9KVUAj3Yy/Q+1OjtHkJ2nPqa07GyWKMM4JI55oAqQwARoWAxnIFTthAOirngetXHZQOVHsMdKz7m5WIBdoyBn3oAbLMA5x1IrndTmlMirGercg1ddzLCJN43qDkVnRurndI2DnFAFJ3b+0J5N4CpgsMdRVdpp3wI+FY8ZFWpFRBNKhUnGW5rLuLmU3EDYBVudooAVp53llEnloqH+E5JArIaRp7oMoXaW6ntVq4wbvKjCMeRnqaquGW4wi4V+DQBSuJc6gihSGBGfTioZNqSS3LZLuGQL6fT2qTDMrxyKQWJHFR3LbyEPylcLj0xQBlzx/6dGjsSqrkj8OlZtypMNxnaNy5XFbF0zb0YhdjqXB7n0FY902IMvnIOCB/IUAc0+duCORULZxVi4GJHT0PHrUDdAKAPur4T/8AJLPBv/YFsv8A0QlFHwn/AOSWeDf+wLZf+iEooA8t/bP/AOSYaT/2GYv/AERPXxoa+y/2z/8AkmGk/wDYai/9ET18aHFADGFMPBz6c1I3So2oA2rV90QP41o27cCsXTJMptJ6cVq27c4NAHReHbv7LqttIThWOxvxr0a6bMijOe4FeTRMVAIPKkEV6Utx9ps7aaM8lQ1AFyJ94+YgZHX3qW0d9+4cfLzzyOaqYJc7CgLY4JwQaflSVcZ+U0AdroN4JLKNdwwDnIraVyRsDAjoCw5rktHl2QqwPy+/at+ymJ+Zm4HG6gC68Ebdc/TNTW9v8wcbd3b/AAqMlCFbG4Zxn2q5ZRsquVX5evJ60ASpJgN+oNZtwoiuWVF5YbgR0qeSVVuETJBc/lVya3IjRio3g4yP5UAZsaS5yODjHXmr9oxKgMuCCDg9jQsWz7+Bz1BpREzN5jfLgjP0oAq662ZgFOVK8/Wqng+1EU16OuGBP5Vc1cRIIpGPQElvSk8Kc2t9d9pWwM98CgBL3mdyclO61kFnBYf7QNaV6ym4bdkcnvxVMRbhICfQhvXmgBApcMMY2kk1WmfJbcSCfXtir0MeckAlWyQc1VuITvLA/KT3H86AK8riWIAN09BXPa9Y5jiuUXI3bHro7O0aaVRuK+o9K09X0xJbYIq/LnP40AcrpsmyNQDwR1/pW9aqXwVAyOx71mXfh+aVGECsrkcMpwQe1c/Ya/qmj3TJcpJKsbbZIpU+YeuDQB0epWTwTeWhYK/48+9UVVwNyE8k7uP0rop9Sju7SOWJg6Mu9eOuax7q8bDKQpIXow4+tAFGcxTg/JiQHGSODjtWRcbkde+QSeOT6AVcnutzlwoG1NoGMD1OKoXUhUsDnkZbnofSgDPvrjy4PmbhQWP19K4W8naeaSRurEn6Vq67qXns8UTfu85ZvX2HtXPzP1oAr3D7VNZFzJhGYmr10+TgGsO+ly2wUAfTv7DrFn8bMe/2H/24ryD4hf8AJQvFnH/Mavv/AEokr179hvr41+lj/wC3FeQ/EH/koni3/sNX3/pRJQBix89TxUy+tQpjPWpQcUATx8f0qdBjmq0eeD1qynOaAJU5P86mQjoahWpovvDn8qALKZLY7VYXhSecdDVePAPGasx/O4UE/McUAdJ4bhaCMyo+1m5966aG/ljIZxlO5rEtE2Qqu0kMvQCtG0jMsm1uAR90nrQB0lpqQ248s4A9etXU1bCgLETjoM1h/Kix5UhhxVqzGCQ3zEnO709qANqPUXb52QDI6Vdt7yTK7AAnqOtYxj3TYDfeHA9K0bSEogAGOO1AGgbxskseM4qRLgyRKQRiq8Nu7MAoL5GDxxWnBp3yLv49qAK8TZi5ByG5wOtXYLV5QjScLnvVuKCKNBtGcnqalLHBAFAAkUUfQZNRz3KoAMj3FMnm2AqOvasy5l3IpQhiDzigCS7uT85VgAPTrisu6lWZN8SF84yzGnTLmVZGYBW/hNRKIkjEaOGyeB2zQBDtJZ9oO0/KMCqsUDfMpyQT83tVvz9mPLclMntzmqtwJDG+2RRuP3qAKUNnFG10lwSRJ0IPSs95bNJD5McokC4FaDoyqWLMSvynJqGVZGnbasang5PPFAGXe+S6wyqRlgcnuDWfI4W4VMsWGTkdDW5eQ+ZhQq7lO4DGPyrOkhE1w5iA+7+dAGXK3myAldu0hh7iqExjLzlm5CEk+melbElqyxOpX5wuazr6Dy7G4OwAsfnI7+1AGfN5cc1spOcQnB9/esS6XFvGDjJJZvWta9d0nMjRgqYwB6Vl3MZLxAYwFOc9TQBg36gTZUYDAHmqjdPWrl/hirAEY4qq2Ae/19aAPuj4T/8AJLPBv/YFsv8A0QlFHwn/AOSWeDf+wLZf+iEooA8t/bP/AOSYaT/2Gov/AERPXxpX2X+2f/yTDSf+wzF/6Inr40oAQ1G1SGmsKAH2b7JsetbsR5Bx1rnMkEEdRW3ZyeZECKANaE9Peuw8MXYNnGjn7jFDnsDXFwtwK2NEuTDcgdnx+YoA7N3KsEwDtbJJ6Z+tXrSRZJNjcoTwSOhrFknR0Q8575/lV/T3VpEYncB0wcg/4UAdbpKBLZ1cjauSxboBnrULawbq4EUPMKt8uehrNnnkuYlsYZCob95Ix7DsKZZ2z9GkxzxxigDu9HnGzLkKoPO48qa1odVtzFIsRJYHaBjrmuPsrSSUr5kiljgfdOT710Gj6YlrIZWkd2J/iGAPwoA1tNsS12t1KDgfMFPP0rWI818qPciqJvY1G3KjHBzVuwuEM4yxxQBCyYDHA9CDVeaQ7HXAUEY9c1pao3luyojNnnisiPdJLhl2qDQBBrts09taRoMF2ww9q0ra2WHTxDHjaBgj3pl2B9pjz0HT+Qq1ACAi9sc0AYk0LPMQAMDg1NBYtsbI6DrUutXtro88Ulw2Xk+6g6mpriOZ1DzSmNSPuLxQBWNqACCO235e1U7qBkDbRuPYdK0FkVVO8sccZzUsao3J55xmgDE0mJpAJMfLnHHqK0QAzlFyw6sai0xglpNbgANGxPP15ot5DHIrMTl/l/woA0IxbISMKrcZqHXLGC7UMwBcjqBzWdeiQOQM9ehH6mia9zBhmI2DOfWgDFVVsj5LYCZynt64qrdrATkE8cA9qj1W4ExztOWJGR2NYF8uy2Z2ZsKM4BxkUATXl3p2noZp5gSvRep/KuH1vWPtu5LdHhhY5bc2Wf6+g9qz55jIzOxyzEnJqlLJQBHK3X09Ko3D4BqWZ+tUJmz34FAFW7k8uMk1hli7lj3q3qE/mSFB0HWqg60AfVH7DnXxr9LH/wBuK8g+IXHxE8W8f8xm+wf+3iSvX/2HevjX6WP/ALcV5F8Sb7T08ceK4pZ9tymtX3y7GP8Ay8yHqBQBhL0GO/WpVHFZiapaADMv1+U/4VKNVssczY/4C3+FAGpHgYyKsRfK2CeKx11ixAOZ/wDxxv8ACp01vTwObj/xxv8ACgDYA556+tSp0GPzrIGvabx/pP5xt/hTh4g01TkXP/kNv8KAN2Lg1f01d92g7DmuXj8SaavBueP+ubf4VpaT4o0aG43z3yKMcfupD/JaAPQ7WUlhHEpzjG70rRiIiIZX8yTjJxzXB/8ACdaEhwuoDaepEMn/AMTVy38e+GogudRLEdT5EnX/AL5oA9BtMGPk7nbnH/160bdMKAwJPp7155D8RvC6hVbVPl7n7PLkf+O1oWvxP8Jjf5mrANxhvs0xz/45QB6Zp9r5gBcfKO57e1dBBFbxxq4XNeX2/wAW/BCQoja0MdT/AKJPwf8AvirI+MfghVG3XGJz0+yT4A/74oA9RVwmAMKD0xxTTNhvmP615m3xm8Ebdo1vPOc/ZJ//AIiopfjJ4KfcDrWc9D9kn4/8coA9QW6wAOgPSqkt71GTtBB47150nxg8EeTtfXCWA4/0Sf8A+IqGb4u+CZMH+2uSMHFpPx/45QB6HNcPumO75SOPWs/zTGhw2TxXDSfFjwXsGzXOen/HrPn/ANAqKX4reC2YbdYGB3+yz8/+OUAdzdsFnTzMsSucj1qrKzKU3LyQTxXHH4qeDHcF9bJIGB/os/8A8RUI+KXg7zVLawSoBBP2ab/4igDsi+ASzH5RkH0qA3zQwZfJVepHvXHf8LM8HP8A6zWCQcjP2abI/wDHKg/4WV4R2sjatujbjH2abP8A6BQB3N1dFwwU5LKCBVVpCJYpRkjGDXKP8TfCBZQurYVVwD9mm/X5KgHxL8KiNwNVBBOdpt5uT/3xQB173AZ4zjDOSPwqjLNhiiqVwfyrmF+I3hTcudUBxnBNtLx/47UT/EPwrl2XVfmJ/wCfeXkf980AdDcSFrkbztypwfXFZl4y/KrjJI3OOxrIb4g+GgxYaiGYggk28v6fLxVO58a+GXDsupZZ1AI8iTjH/AaAL9xKXdAoG0etZkn+sywyeQaoT+L9BeTIvcKOg8mT/wCJqpP4r0dwxF58x54if/CgCO/TZcBQDjriqT++ahv9e02S4Vo7ncuOvlsP6VXbWrAjHn8f7jf4UAfe/wAJ/wDklng3/sC2X/ohKKPhP/ySzwb/ANgWy/8ARCUUAeW/tn/8kw0n/sNRf+iJ6+Ne9fZX7Z//ACTDSf8AsMxf+iJ6+NBQAGmmnGkNAERFXdLl2uYz9RVRqarGN1cdQc0AdPCcHrxV2JjgEcEHj2rLt5BJGCDxjNXoX5GaAOrsbtLyJEZtlwvY9G+laEVx5OeMFPl445rj0YHFWklcgAyNgf7VAHdaZeu73JiA3EDkdcCtkEPCpUAOOvbmuO8NOEKM/IZ+5rpzccusR+XBAHTp1zQB0GmXHkzfO5Ygghc1qC+knbAfaAccCub05l81WUEtjOfQY5rTsHCXPOVR14OfbpQB0ML5Odm5m6hq3NIfZKmQCvTGKxrZcquVx+PUVqWZO/kkDp7UAaGvzt8iqwCYJOO9UbUZQNx7U+/Vtod13r2Cnn/9VVrW8SORhkuAvIAoAtX6EozYycdvWmxX8gVEhhzMeMnnBqF7ksDG2VBGQvpVqwmDsBGAM8H1NAFHVdPUQpdXOJLmJtwJ52561cjY3GnAk5ccHvmptajb7DLnHK4/HNY2m3DW6SRnPl5zz1FAF4QAr16j86guRiNdvYVMI7mZNyghegJ4z702SznA4CsMdQaAMy2KpqBuoyMPw69we9TakjYBBBB5ye1ZWqB7aUuEZGAww6Z+lVo/ELm3UFhIAeN1AGsJPPXEhHmgD589ay9SdoSPL+5+ZJoGpicEghO2C3JP1rntVv3fA3t8uVAc8ntQBX1Kfy5WBk3nHVegP19azNTvvM0y4BkBbyyQfes+7kWNBGrKVXJODWDqd9vTyo+nfB4oAzpH+XHtVSVjT5H5xVSZ8AjvQBFPIemcGs7UJxFFgHk1YkfGTWJdyGSbHYUAQcnk9aVetHalHWgD6n/Ye+941+lj/wC3FfPnxY/5Kn4y/wCw1e/+j3r6D/Ye+941+lj/AO3FfPnxY/5Kn4y/7DV7/wCj3oA5SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/Sr4T/wDJLPBv/YFsv/RCUUfCf/klng3/ALAtl/6ISigDy39s/wD5JhpP/Yai/wDRE9fGlfZf7Z//ACTDSf8AsNRf+iJ6+NKACkNLRQAw0wipCKaRQBa0yfy2MbHg8ittW7iuYyVYEdRW1Y3HmRjJ5oA2InztPFWY26VnRNjAq3E9AGzY3vkoiHOFOcrXTafqUd1hI22SddrD72PSuJiOGxnNaNtIY2SRSd6nIoA9Bs5cujKuXAP/AAIVpgkkGMDttAPQDkmud0y4MhRwQDyCPr3rpIVG1MkE4xx39aAOl064RrcfMQSdoOO/rW7aHjtj19K5GwUiVTuJXsp710lq25QrDAx3oA2QomXY3QjGaxZsRD5B8ynaSP7taalljG04K9j/AJ61kyESSsnOCfm9CfSgCJj5YdurAcDPPvU1ldvbztkArnnHpUaoRbr+7+cblz6j3NRRj5yTggfMD6UAdNeTJc2QCsCGHaucLqsqR87mIB9etBkYQfNnGc56f5FZhgla7EyTybUGWHZvegDuXfZhTx6elVJLtBn+Eg9Omaoxy+ZDGzMSV+Utms7UN4yBjKnOPb1oA07q7iEe2VkIOeG5ya891HToCHkgJhYsW4B25z3FbV1MVkJLsCB8vckd6zrqY4f5shm259upoA4+9vJ7SQxXAZWPIx0YeoNZ1zqjOhRgxAHAHaus1AQ3EJjuYlKnJx6fQ1wmqwfZZzGG3KRlWPXFAFG6maT7zceg6VnzN8wFWpW/KqUxycd80AQO3eqU7c4FWpDwaoyHkmgCney7IzWSPU1a1CTc4UfU1WFAC44pB1pwpO9AH1N+w997xr9LH/24r58+LH/JU/GX/Yavf/R719B/sPfe8a/Sx/8Abivnz4sf8lT8Zf8AYavf/R70AcpRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfpV8J/+SWeDf+wLZf8AohKKPhP/AMks8G/9gWy/9EJRQB5b+2f/AMkw0n/sNRf+iJ6+NK+y/wBtD/kmGk/9hmL/ANET18aUAFFFFACEU0inUhoAjIqayk8uXHY1GaZnDAjtQB0kL7lHPIq5E2cZ7Vj2Mu5BzWnE+OaALqsQwrQtn4AzWWp4/lWjp6GWQJ1yRnFAHa+GYcok90dsbECNSfv89a9L063tp7fY0YUEcbeCK4HTV82dQoxGgGzI64HQV1+lo8cnys25RnB9BxzQBvrYGAq0ILx92xz+NW4Bt5B69Qf6U2wvBjE/ynAHPT86t3QSJtyMpU8jBzg0ATL/AKrJHIHSsK6BjvZGACjuc1eS5+U4IznHWs8BpJZGzweoHagCRpvMt9xJDgnBB4HHXFIkjRvI5XIwq4HfvS7f3g2BgMZIx1NKoORtGSfTp70AMmXktI33+PqKtwx7V2sMluMU0pOZDgZUd/Wp1EhbnaCOpx3oArWhKpIgOQOnqcUy+P7vd3PHseKmtbcncWH3iSSaS4QKoAOQRgntigDmtyRyJvYIq9FbnNRyBZBITgKBtz369T/KtLUmgeP58YHP1qrFbQ3KrvlCREZkQnvQBi6hH+6ACAHbkBuAK868QTCTUHRcFIhsBHTPeu18bazbW2LazLy3BGTIRhUX29a84n75Oc9T70AQS9Pr2qnIfWrEhyT6Cqsx5JoArzdOlUZjhTzVuY8HNZt++2I/SgDKlbfKx98ULTVp4oAWm96fimHrQB9TfsPfe8a/Sx/9uK+fPix/yVPxl/2Gr3/0e9fQf7D33vGv0sf/AG4r58+LH/JU/GX/AGGr3/0e9AHKUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH6VfCf/klng3/sC2X/AKISij4T/wDJLPBv/YFsv/RCUUAeW/tof8kw0n/sMxf+iJ6+NK+y/wBtD/kmGk/9hmL/ANET18Z0AFFFFABQaKKAGmmGpDTDQBY0+Ta5U/WtuI54rm422Sq3vW7btkCgDRiJxW7oHz3aKPvbgR71z8TdCK0NPuWtbqGePO6NwwoA9M01WhkDbiwHOen5V22jXCOOQgeTGf8ACuO0G/hvLLMm0biQGB7f54rWhcQPujOFGNoPYUAd3HAr/wCrIyeSMd6W+gDRFWUAEYx3xWLp944OQSUXGBnqa2PtYl4IAxxzz+VAGLHBJYyM8hLRHnH8vxrSsodyB0bg9+1Mv1M9wkYUhFGT6URLLbnEWcfTINAE8x2FuBg9h3p1su+RU4xmoLk7kVnjYMOm3pTNLuVN6sYicuAcluMUAbrKFAwen5Vm3t2yb44hubGSR06VbkEkrYPC4PA4/Wqk0JtgxAGcUAQ22oQta5BG/wDjXoVNUry9V8FHG7+6e/NOumDAvsUMozwB+VZ10iOp3fIw5yehzQBR1K53JjaxOQoVfT1phvYrWxlklZmEWWJx94dhVmHTZ5GkfGUBADdAR/hWbqtvJdIYkb9yp4HY+9AHnupXMl5cSXEpwzHgf3R6VjzEnJHSuk1mxMYaRFII++vr7iudmBHSgCkc/MKrSnLVZf77Gq0hyc0AVJu351j6o/GPU1rydfpWFqRzKo59aAKwp60wU8dKAHUw/ep9MPWgD6m/Ye+941+lj/7cV8+fFj/kqfjL/sNXv/o96+g/2HfveNfpY/8AtxXz58WP+Sp+Mv8AsNXv/o96AOUooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP0q+E//ACSzwb/2BbL/ANEJRR8J/wDklng3/sC2X/ohKKAPLf20P+SYaT/2Gov/AERPXxn2r7M/bQ/5JhpP/Yai/wDRE9fGdAAaKKKACiiigBDTDTzTWoAjateyfMamsg1p6cf3YA9KANeI8+1WojyKqRdKtRk5oA63wndtDHLF/Bu4H1FddBd7oQjcgAYBODXnmiziK42k/fGPxrrLWT5drEk5z/hQB0qXLKoCnAALsA2CM9M+orQsJyALhyQCemckkdgPSuVe9OCxIJJ4XHc8Vt2pYBFZiPcc/lQB01rfOHklc9efmHf0rd07VImG2RgOoAIrk1zEhUbsE7mBOPoBV+1ASEj5gzD8QaAOwAt54ycKfpTYdPtRco4yGHGc9a5VJGU7skcYwvar9m808kb2+9gDwxPBwe9AHRSBI8gHnsKzrxf9HlaRRjHA9604LUSDO4OCcnHamajaK0YQZ+lAHISbmIwmT0x71La6W0xDTgEKeh/SttbVIxlmBI5yRVa7uWYGK1UhQOXoAoai48s2sB3ZGGI/lmsC8hC/Jk5HJA6106WYigaRzwegxzWBfLlnZtwwcKR1NAHL6nAH34XDH+Fhzj0rzy+hME8sR6q36V6Ff5BKlj5iDnjOOef0rj/Esf8ApHmDPHy59RQBzkw61UlPB5q1JwzVUm9KAKkvf0rAvjm4PsK3ZT8p4rn7g5uH570ANFPFMFPFACmoz1p5pp60AfUv7Dv3vGv0sf8A24r59+LH/JU/GX/Yavf/AEe9fQX7Dv3vG30sf/bivn34sf8AJU/GX/Yavf8A0e9AHKUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH6VfCf8A5JZ4N/7Atl/6ISij4T/8ks8G/wDYFsv/AEQlFAHlv7aH/JMNJ/7DMX/oievjOvsz9tD/AJJhpP8A2Gov/RE9fGYoAKKKKACkopaAENNNONNagBhrQ077grPNaNgMRrQBrRc1YQ1ViPSp06+1AF+M4AIJBHQ1s2+oyrHsfLj1BwaxIjwM1biNAG3bXJnurcNkKZFB/OvRfLxeNGg28j5s9PpXlkOccHB6g/1rutF1uK7WKO7wt0uAG7SH/GgDqV2naw5AJBB5xVhQzJIIxlmyqkn360+1s4+F3kt1wegrbs7BYwOmCMetAFOw095JEZmxGoxg9TXRwW2xUAOEXoAMVJZQgtngKO1WZZEVAcE/SgBlufK+6SMd6z7meeaVssVGcDjtU8zzSJt27V9qntbB3y03yLn8TQBnLaySyZbLH9KnaKG2Qb2G49wKuXcsdsh+bp0GOtc9qUxllAdgNnzZB4PpQBX1O9aWPMAJ5xgd65q+3qkrKQhZ1UA/ex9avXDrF5UeWboPkPHPOaxbh2fyydzbSRjPU+pNAGdeYaXdglTKQcnBBI6VzOsxBlkTu2c98d66GUlUZmJ3EkgsOh7/AKVh6gETfgYGSf0oA4yXk59RVObrV2YYYj04qjc85z0oAo3B/dHnk1z0n+tb610F1xFj2rns5Yn3oAcOtPFMWnigBTUZ61IaYetAH1L+w797xr9LH/24r59+LH/JU/GX/Yavf/R719BfsO/e8a/Sx/8Abivn34sf8lT8Zf8AYavf/R70AcpRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfpV8J/+SWeDf+wLZf8AohKKPhP/AMks8G/9gWy/9EJRQB5Z+2j/AMkv0n/sMxf+iJ6+NK+zP20P+SYaT/2Gov8A0RPXxnQAUUUUAFFFFACGmnrmnGmGgBvUgetatsMAAdqzYRmUfnWpB70AXU7VYj+9Uljaxuqmctlh0X+Eds066tmtJwjcqwyretAEkR5GKux9BjpVGPqDV6DGP1oAuQdK3dCiEt6pI3LH8341h2waRwsSNI3oi5rrNAsbyKOSRreZCxAGF5IoA6zTJJg2VdkCjnmt60uZ5FYmZ8DkDPWuZsJhvUEBSp+7/j711OjBJpVBHAOTQBrWJuGTJLEn3rXtrO4kAMjbRnI3cEUttcpCiqFAA9BSPqAypU9TyaANOGCOHk/M3qegqteXp+7GfbArOubt2f7+c8EVnyynzMnnuRnqKAJppWcNvdAOoAPT1qhcBCCUjMny7SCahlJ+Vc5OCeO/tVRzKr/K+3kcjt9aAGXKOdiJ8mBtwqjp9TWPfW7mUlMbixIAHUY/xrSnYhidzZ6qf0qnceYVyWPGSe3FAHP38EioxbHCljnnJ6Vzupkt5gxg5IAIxwcf4V1F8reWxBwQcncPyrmL7PLNnOcg+tAHI3n+vc9jWbcdPxrUvR/pM3GBu7VmXQPGcUAZuoNiBvpWAK29VOIT9Kwx2oAkFPFRipBQAGoz1p9MPWgD6m/Yd+942+lj/wC3FfPvxY/5Kn4y/wCw1e/+j3r6C/Yd+942+lj/AO3FfPvxY/5Kn4y/7DV7/wCj3oA5SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/Sr4T/wDJLPBv/YFsv/RCUUfCf/klng3/ALAtl/6ISigDyz9tD/kl+k/9hmL/ANET18aV9l/to/8AJL9J/wCw1F/6Inr4zoAWiiigBKWkpaAGnpTTTzTDQA62/wBYfpWjFzgdicVnQH95V9DhTQB1duoXJIb5Txjv6CtOe1TUrRY1kUTp8wZuM1k27iSInGSyg/pVu2ZmPUkAcn2+tAElj4c1a5mEcVrkZ5fcNqj1r0XTPAejWkSy6pdzTsQCF3bVJ/CsHRJ5o4gkTFn3AEZ7Vv28iTKrPJlypXGeNwPX88UAbcMWiWabYYQoGPlDYx+VaFpd2QyscTKOvrz0rnYkBb94Rvxycjjj/GrqgA+x53ZzzQBZ1qBQVu7dSNp2yD0HY1f0SYecvbjofTvVSC4DJubpjY47GksCIpnVemePb0oA65mbaVweegpQ7H2weP8APeoraXzIRknI6c84qSPhs5yR+lABI2ckHkD86gkQ5cOcA9Papm6dge350xlyxOSc/oR3oArv1cKcEe2KrS4EhyNwI5NWSDubk529R61XnwFOcgq3PFAFOZ96qFB4Xn6VnzEyptZWG7nav9a0SoDdSAw49eKpSM+WwCEzyR16UAY2pjch67c/ebqTntXN36bg2ThVOeP4QOa6bURwT2HQd65XXnEGmXOCS80gjB+nWgDjJm3l3z95iaoXA5IxV+UfIfzqjPywHrQBiawf3ZrHFa+tH92frWQKAHrTx0pg606gBajbrTzTG60AfU37Dn3vGv0sf/bivn34sf8AJU/GX/Yavf8A0e9fQX7Dn3vG3/bj/wC3FfPvxY/5Kn4y/wCw1e/+j3oA5SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/Sr4T/8AJLPBv/YFsv8A0QlFHwn/AOSWeDf+wLZf+iEooA8s/bR/5JfpP/Yai/8ARE9fGnavsv8AbR/5JfpP/Yai/wDRE9fGdACikpe1JQAUUUUAIelNNPNMNACIcSCtCI1nHjmr1ucqKAOg012eGEKDnBX6EVrQDsxwPQn9KwdGc+a8OcbxlT6EVuW/KgnOD15oA6DTWGzG0/OME9xjkYretA2eChIfce3XgGsHSQUdGJ5XoOvODW1aKAMrjON2SOwPf9aANe3PzgMcbhjJ55q0Hyuc8k+lU4htcKOdvOB2q2CWUgnJHPHGPagB8T7Z9hBVG/Cp7aQi5fBHDEZqjtLMpB64xz0/zijRLs3kUjfLv3nI/GgDtbCb5AeckdqvKc8nkEVk6e5Kd9pOQc1qwtgKSMK2cHNAE+AcfNwegxURHHX5uacrBe5OAO9EhCnDDKkc0AV34dhzzzx3qnMSXOWxnnircy8PtyOnNV7lW3EhRg0AU3GFzkHBBye+etVrjI3NvC8/MParcn3hwMeg9M1VuhjGB94H9DQBiXYUhzncPb1rifFkuZorbI/dLubHqa76QBVklbGFBZsdOK8u1CUz3E0r/ekYtQBlzZwc1Qm5atCccH1xVCQ80AYGt/d/GsoVqa52/wB6ssUAPFPpi9acOlABTDTzTGoA+pv2HPveNfpY/wDtxXz78WP+Sp+Mv+w1e/8Ao96+gv2HPveNfpY/+3FfPvxY/wCSp+Mv+w1e/wDo96AOUooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP0q+E/wDySzwb/wBgWy/9EJRR8J/+SWeDf+wLZf8AohKKAPLP20f+SX6T/wBhqL/0RPXxnX2Z+2j/AMkv0n/sNRf+iJ6+M6ACilpKACjvRRQAGmmnUhoAjNWLQ8EelQGpLU4lwfSgDWgkMbpKv3kOa6+3G8gqQFYbx+PauOi5rqfDzmaw2HloDsPrg9DQB0mmDOwgdjz6nNbMWQ4zzxkj9cVj6eCPukknJx3wOtb6KvmrnOBkfU0AWo1O5WHGepzViMZbu2VAOKgiO6NQVGccf4n8asxjb83Gdi8D9aAAqNjlVwF5yPTB61zfh+7NveITyshwfrXUT/Lp13Lzny25z7Vw1vnYhBII5FAHrVgwBwOFb5h9a2os+UMc84+lcl4euvtNtCc/NgZ+tdVAcqAe4xQBYQ5AJx6Yob73B9R9aYrY6DIyM+9OlJIHPIX096AID0Y9uvPbtUFzhAxUcgA49asSjkgYbJ6ehqGb51J3AkDpQBTbG3GBx6dagmXKAjkqe3erBXBLZJU4GfxpGAztC8ZHSgDmPFkgttDm2n5pDt/OvM7xTgbe3FegePpCq2sPYtuIrgbw4Iz0zQBnXAwMd+lZ7dQK0rnGW5rOP+sxigDndd++PrWYK0td4lH1rNFADx1p1NFOoAKa1OprUAfUv7DnXxr9LH/24r59+LH/ACVPxl/2Gr3/ANHvX0F+w597xt9LH/24r59+LH/JU/GX/Yavf/R70AcpRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfpV8J/+SWeDf8AsC2X/ohKKPhP/wAks8G/9gWy/wDRCUUAeWfto/8AJL9J/wCw1F/6Inr4zFfZn7aP/JL9J/7DUX/oievjMUALSUUUAFFFFABSGlpDQAw0RHEqn3xSmmdCD70AbEJ+7iug8LS7NWERPyzoUx79RXPRH5Qe1aFpMbe4hnHWJw360Aej2SqJiQAflAwa3oxnZkk4wxGOtZsCKJiVHDAP9VIyK2oEVlAIJ56e2KAFwQuFXlRgH6irSbSQFHVsYFQopJwSQSWK/QdKmj+4CeBu3Aj0oAbqJ26FesGziPaPYVxkIPlqOOgrs9eG3w5eHGCQBXGxfdXtxQB0nhS48q7MJPDcivRrRj8pHpya8isZjBdwS9lbB+leqaTN5sCupHIwfegDRUE4OcZHB+lPJUkc/K1KFyD6A7hSMOML1xkUAVwCeTwFbvxmopB8xXHbg1YfO0njK9aZIDknk5FAFTHynOMEZOfWkCEuM9+1SEDcQCcNn+VEYBZTjnH5cUAec+Pn36tEox8qE4/GuMvV5rrPGZ3a7IOOIwP1rlLvqKAM2f7pJrPH+tP1zmr9x0Iqj/y149aAOb8QDE4+tZg61reJBi4X3rJFAD1p9MFOoAKa1O701qAPqX9hz73jb6WP/txXz78WP+Sp+Mv+w1e/+j3r6C/Yc+942+lj/wC3FfPvxY/5Kn4y/wCw1e/+j3oA5SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/Sr4T/8AJLPBv/YFsv8A0QlFHwn/AOSWeDf+wLZf+iEooA8s/bR/5JfpP/Yai/8ARE9fGW4DgkD8a+zf20v+SX6T/wBhqL/0RPWF+zV4ih8J/s/eLdduNpSx1GeVVbo7/Z4Ai/ixUfjQB8n7l/vCl/Wvtn9m/wCIus+KZtY0bxZqtnqeq28cF9BPbeVgwyIpaP8AdgLmNiA3GQWIycCviVPuL9KAFooz6UUAFBopKAGmmN0p5ppoA0rU7ox9KvRfMmPUYrNsTmMD04rQt+nFAHqnhyQ3Wg2EvJcR+Ufcg4ro7XIOFyBgEEVyHw6l83RrmDJzDNnH1rsbfHygDaQcDHoO1AFiZSFYqQcD5TTgP3eAMAcVIVyGxyQcZ7Z9aREGFA4HXBoAra/x4YugD15/WuPiHyg12niEY8NXXIPFcTH9wHmgCx1HHevQ/B10ZLKPnnHNeeoMg966jwVOElaLsDn8DQB6LgY44yByTTpASMnsaanzR5+lSY+6TjB4xQAxhlsHGG4qBwW2ZOPcdKmkGSCeowR7VEdxLFfqBQBWl+by8gDIOMetOhBLse46090AcL/DnNJbrgsM54NAHlfi8f8AE+uP91a5a5HzGus8agrr83bKL0rlLkneDQBmXH6ZrPOBJ16mtGb71Z8vEn40AYPiZfmhb1yKxRW/4mXMEbejVz4oAeKkqNaeKACmtTqa1AH1L+w597xt9LH/ANuK+ffix/yVPxl/2Gr3/wBHvX0F+w518bfSx/8AbivJ/wDm6f8A7nP/ANvqAPKqK+zviR428aWXjbx5aaDf6itpodja3cCW8Fm0MAZA0jT+avmsmNxxHkj6VxX7Yeopq/h74bajFNHOl3a3M4ljBCvuW2OQDyBz0PNAHzNRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB+lXwn/5JZ4N/7Atl/wCiEoo+E/8AySzwb/2BbL/0QlFAHln7aX/JLtJ/7DUX/oievGfhR8QvBGjfDa/8K+O9H1fU4LnUzf8Al2m0RkCOJVDHzUJwyE45HSvrT4n+ANL+I2gW+ka3cX1vbQXS3atZuiuXCOoBLKwxhz29K8x/4ZY8Ff8AQW8Sf+BEH/xmgDGk+P8A8Mn8VQeJD4d8SDWoLY2aXKxxL+5JJ2FRPtIySeQcV8lqMKM9QK+zv+GWPBX/AEFvEn/gRB/8ZpP+GWPBX/QW8Sf+BEH/AMZoA+M6DX2Z/wAMseCv+gt4k/8AAiD/AOM0v/DLHgr/AKC3iT/wIg/+M0AfGVFfZn/DLHgr/oLeJP8AwIg/+M0f8MseCv8AoLeJP/AiD/4zQB8YmmGvtH/hlfwT/wBBbxJ/4EQf/GaT/hlbwT/0FfEn/gRB/wDGaAPjiwb7w961IThjz1r61T9lnwUhymreJQf+viD/AOM1KP2YfB4ORrHiTP8A13t//jNAHz/8MZsaleQE8SIDj36V6Hb4AIJ6HOD+hr0rTf2dPDemXP2iy17xJFNjG7zbY8fQwYrT/wCFI6Zkn/hJvEmT15s//kegDzCP5lIznggj36UgTk9ckfrmvU1+C9gv3fFHiQf+Af8A8j0v/CmbDj/iqfEvByP+PP8A+R6APKtaTzPDl2O+w9vauBj5jX3FfScnwYsJIHhfxT4kMbjDD/Q+f/Jes5f2ftAUYXxD4kA6fftf/jFAHgsJIxxWv4fm8nUk5wGBFeyj4A6GOniLxL/33a//ABinx/AfRo5A6eI/EoYdDvtP/kegDMtG8yBWA6rUwDFWII4GRXSQ/CqOFAsfi7xIFHQbbI/+21PHwuUf8zf4k/75sf8A5GoA5d+VDAnnBqJsZVuRzzXW/wDCrV/6G/xL/wB82X/yNTT8K0br4u8Sf982X/yNQBx5AyFIPHNFuMSYPbI/Cuv/AOFVR5z/AMJd4l/Ky/8AkalX4VRqcr4u8SA/7tl/8jUAeBeO1xrzdMGMVyFyvJr6Z1D4G6TqE4mvPEviSSQDbndaDj8Leqbfs9+H2+94g8SH/tpa/wDxigD5fuOvvWfdDBYjtX1U/wCzl4Zc/NrviQ/9tbb/AOMUxv2bfCzddc8SHP8A01tv/jFAHyL4gXdp7nuCGrmBX27N+zN4SmjMcmteJGQjBHnW/wD8Zqp/wyr4I/6CviT/AMCIP/jNAHxetPB4r7N/4ZW8E/8AQV8S/wDgRB/8Zpf+GWPBP/QW8Sf+BEH/AMZoA+MvWmtX2f8A8MseCv8AoLeJP/AiD/4zR/wyv4J/6C3iT/wIg/8AjNAHK/sOdfGv0sf/AG4rxjxDqsGg/tD6nq94sr22n+KZbuVYgC7JHdliFBIGcA4yRX2f8KfhVonwz/tT+wrvUrj+0fK837bIj7fL37du1Fx/rDnOe1cf4h/Zq8Ha9r+p6veal4gS51C6lu5VinhCB5HLEKDETjJOMk0Aef638Yvg/rerahqWo+HPFz3WoIkV4Yp2hS4RAAquiXQVgAOhGK8//aF+Jvh34g2vhe28Laff2NvpCTxmK5hjjUKwiCKgR24AjIxxjivcP+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+KqK+1f+GVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA9V+E//ACSzwb/2BbL/ANEJRW14e0qDQdA0zSLNpXttPtYrSJpSC7JGgUFiABnAGcAUUAf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The oblique view of the left wrist (A, magnified in B) reveals a fracture through the mid portion of the scaphoid (arrow). The fracture fragments appear to be in anatomic alignment in this view.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2180=[""].join("\n");
var outline_f2_8_2180=null;
var title_f2_8_2181="Duodenal transection during total gastrectomy";
var content_f2_8_2181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Duodenal transection during total gastrectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 715px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The duodenum is transected just distal to the pylorus using a gastrointestinal anastomosis stapler (GIA) device. Care is taken to preserve the structures of the portal triad. The duodenal stump is oversewn using a 3-0 Prolene.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2181=[""].join("\n");
var outline_f2_8_2181=null;
var title_f2_8_2182="Gabapentin: Patient drug information";
var content_f2_8_2182=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gabapentin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     see \"Gabapentin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/23/35191?source=see_link\">",
"     see \"Gabapentin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F175023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Gralise&trade;;",
"     </li>",
"     <li>",
"      Neurontin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F175024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Gabapentin&reg;;",
"     </li>",
"     <li>",
"      Auro-Gabapentin;",
"     </li>",
"     <li>",
"      CO Gabapentin;",
"     </li>",
"     <li>",
"      Dom-Gabapentin;",
"     </li>",
"     <li>",
"      GD-Gabapentin;",
"     </li>",
"     <li>",
"      JAMP-Gabapentin;",
"     </li>",
"     <li>",
"      Mylan-Gabapentin;",
"     </li>",
"     <li>",
"      Neurontin&reg;;",
"     </li>",
"     <li>",
"      PHL-Gabapentin;",
"     </li>",
"     <li>",
"      PMS-Gabapentin;",
"     </li>",
"     <li>",
"      PRO-Gabapentin;",
"     </li>",
"     <li>",
"      RAN&trade;-Gabapentin;",
"     </li>",
"     <li>",
"      ratio-Gabapentin;",
"     </li>",
"     <li>",
"      Riva-Gabapentin;",
"     </li>",
"     <li>",
"      Teva-Gabapentin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10922616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or control seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat painful nerve diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692040",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat restless leg syndrome.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hot flashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702177",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gabapentin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow laws about driving with a seizure problem.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434399",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not the same as gabapentin enacarbil (Horizant&trade;). Do not use in its place. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697935",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Problems with how one acts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698036",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Emotional ups and downs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698155",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hostility.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698512",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If seizures are worse or not the same after starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705419",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Fast release:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3311838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Extended release tablets:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546522",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with the evening meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694694",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705565",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablets and capsules:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12504 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-B4DFEB0FC9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2182=[""].join("\n");
var outline_f2_8_2182=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175023\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175024\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10922616\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012110\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012109\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012114\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012115\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012117\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012112\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012113\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012118\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012119\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=related_link\">",
"      Gabapentin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/23/35191?source=related_link\">",
"      Gabapentin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_8_2183="Surgical management of metastatic melanoma";
var content_f2_8_2183=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of metastatic melanoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Michael Stone, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Michael B Atkins, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Russell S Berman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2183/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/8/2183/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 23, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the incidence of malignant melanoma is increasing, most cases are diagnosed at an early stage. In that setting, surgical excision is curative in most cases, and patients at high-risk of developing metastatic disease may benefit from adjuvant therapy with interferon alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26585?source=see_link\">",
"     \"Initial surgical management of melanoma of the skin and unusual sites\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44711?source=see_link\">",
"     \"Adjuvant immunotherapy for melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of patients with disseminated disease is a difficult problem. Systemic approaches that have been shown to provide clinically important benefit for appropriately selected patients with disseminated melanoma include immunotherapy with high-dose interleukin-2 (IL-2), immunotherapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/52/19270?source=see_link\">",
"     ipilimumab",
"    </a>",
"    (a monoclonal antibody targeting CTLA-4), and inhibition of the MAP kinase pathway with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/48/17159?source=see_link\">",
"     vemurafenib",
"    </a>",
"    in patients whose tumors contain a V600 mutation in the BRAF gene.",
"   </p>",
"   <p>",
"    The role of surgery in the treatment of metastatic disease is discussed in this topic. An overview of the management of advanced melanoma is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15558?source=see_link\">",
"     \"Overview of the management of advanced melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434153966\">",
"    <span class=\"h1\">",
"     RATIONALE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have limited sites of metastatic disease may be amenable to surgical resection and complete surgical excision of limited metastatic disease can result in prolonged relapse-free survival in carefully selected patients. Surgery for distant metastatic melanoma, however, is rarely curative since the majority of patients with distant metastases have widespread micrometastatic disease even if clinical and imaging criteria suggest limited spread. Resection should be reserved for the relief or prevention of morbidity due to local tumor growth and for patients in whom a longer survival might be expected with surgical rather than medical treatment. When surgery is considered, careful patient selection is important and treatment must be individualized. Factors to be considered include the severity of symptoms, pace of disease progression, previous treatment and treatment response, patient age and medical condition, and the desires of the patient. Quality of life should be the principal goal of treatment for many patients.",
"   </p>",
"   <p>",
"    The potential for complete surgical resection to benefit individual patients is suggested by the results of a prospective, phase II study from the Southwest Oncology Group [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/2\">",
"     2",
"    </a>",
"    ]. In this prospective, multicenter study, 64 of 77 carefully selected patients were able to undergo complete resection of all sites of metastatic disease. At a median follow-up of five years, the median relapse-free and overall survival durations were 5 and 21 months, respectively. Overall, the three and four-year survival rates were 36 and 31 percent, respectively, although late relapses continued to be observed after this time.",
"   </p>",
"   <p>",
"    Similar disease-control and survival rates were observed in a phase III cancer vaccine immunotherapy trial, which included 263 patients who underwent complete resection of all metastatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=see_link&amp;anchor=H100469011#H100469011\">",
"     \"Interleukin-2 and other immunotherapies for advanced melanoma\", section on 'Whole cell or cell lysate vaccines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CRITERIA FOR SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several prerequisites must be met before attempted curative surgical treatment of metastatic disease in any malignancy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The primary site must be controlled or controllable",
"     </li>",
"     <li>",
"      The patient must be medically fit to withstand the planned surgery",
"     </li>",
"     <li>",
"      No other nonsurgical curative treatment should be available",
"     </li>",
"     <li>",
"      The specific cancer should exhibit a metastatic pattern in which a significant percentage of patients have solitary organ or site metastases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with metastatic cutaneous melanoma frequently present with involvement of more than one disease site or organ. More so than with other cancers, melanoma is capable of involving every major organ within the body. Despite improvements in radiologic methods, the extent of metastatic disease in patients with melanoma may be underestimated by physical exam and imaging procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following potentially curative resection of a cutaneous melanoma, routine monitoring of asymptomatic patients should focus on those sites most likely to harbor metastatic disease, particularly those sites that may harbor potentially resectable metastatic or locoregional disease. A careful history and examination of the skin, soft tissues, and all lymph node basins should be routinely performed. Many sites also recommend periodic chest x-ray and serum LDH. More sophisticated imaging studies (CT or PET-CT scans) should be performed if symptoms, physical findings, laboratory, or chest x-ray abnormalities are documented. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35065?source=see_link\">",
"     \"Staging work-up and surveillance after treatment of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If metastatic disease is identified, we recommend the following diagnostic evaluation prior to any surgical therapy to determine the full extent of disease:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Magnetic resonance imaging (MRI) of the brain",
"     </li>",
"     <li>",
"      Torso CT scan with and without contrast",
"     </li>",
"     <li>",
"      If soft tissue metastases are present or the malignant nature of particular lesions is unclear,",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      scan may be added or substituted for CT scans",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Positron emission tomography with F-18-flourodeoxyglucose (FDG-PET) may help distinguish malignant and nonmalignant tissue or reveal additional sites of occult metastatic disease, thus potentially altering the treatment plan. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15450?source=see_link&amp;anchor=H3#H3\">",
"     \"Imaging studies in melanoma\", section on 'Nuclear medicine techniques'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H434154051\">",
"    <span class=\"h1\">",
"     INTEGRATION OF SURGERY WITH SYSTEMIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection of oligometastatic disease is sometimes useful in carefully selected patients after systemic therapy, particularly those with a good response to immunotherapy with either high-dose interleukin-2 or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/52/19270?source=see_link\">",
"     ipilimumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/4\">",
"     4",
"    </a>",
"    ]. Although this approach has not been proven to prolong survival, a significant number of these patients can achieve durable disease-free survival after such surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15558?source=see_link\">",
"     \"Overview of the management of advanced melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical resection of oligometastatic disease does not have an established role in patients treated with targeted therapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/48/17159?source=see_link\">",
"     vemurafenib",
"    </a>",
"    ) for symptomatic metastatic disease since these patients almost invariably relapse when treatment is discontinued. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=see_link&amp;anchor=H100472992#H100472992\">",
"     \"Molecularly targeted therapy for metastatic melanoma\", section on 'Vemurafenib'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/28/2506?source=see_link&amp;anchor=H175769012#H175769012\">",
"     \"Advanced melanoma: anti-CTLA-4 antibodies and other immune checkpoint strategies\", section on 'Ipilimumab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SURGICAL MANAGEMENT OF SPECIFIC METASTATIC SITES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Skin, subcutaneous tissue, and lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excision is the fastest and most effective treatment for isolated or limited skin and soft tissue disease. Complete removal with a small margin of normal tissue is appropriate for a local recurrence, in transit or satellite metastasis. Extensive extremity skin or subcutaneous disease may be treated with hyperthermic isolated limb perfusion or infusion in specialized centers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/28/27081?source=see_link\">",
"     \"Cutaneous melanoma: Management of in transit metastases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34007?source=see_link\">",
"     \"Cutaneous melanoma: Management of local recurrence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Resection of isolated distant lymph node disease may provide palliation of symptoms or prevent morbidity from venous obstruction. However, deep iliac and aortocaval nodes that are replaced by melanoma may be difficult to dissect away from adjacent vascular structures.",
"   </p>",
"   <p>",
"    Several studies have reported significant survival rates for patients with subcutaneous or distant lymph node metastases.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 114 patients, the five-year survival after surgical resection was 33 percent for patients with subcutaneous metastases and 22 percent for those with distant lymph node metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another series of 60 patients with superficial inguinal lymph node dissection and 72 with combined superficial and pelvic lymph node dissection, the overall survival rate was 34 percent at five years [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/6\">",
"       6",
"      </a>",
"      ]. In patients with combined dissection, five year survival was significantly higher in those without than those with pelvic lymph node metastases (47 versus 19 percent).",
"     </li>",
"     <li>",
"      Among patients with melanoma metastatic to inguinal nodes, the extent of nodal disease does not appear to influence prognosis. In one series of 227 patients undergoing inguinal lymphadenectomy for cutaneous melanoma, the five-year survival for patients with superficial or deep nodal involvement was 40 and 35 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to recognize that, in addition to suffering from selection bias, these studies of subcutaneous and nodal metastases do not account for the impact of any subsequent systemic therapy on long-term survival. Another problem is that more recent lymphatic staging techniques indicate that many patients have drainage to more than one regional lymphatic basin, suggesting that, in some instances, nodal recurrences thought to be distant metastatic disease (Stage IV) may actually have been atypical regional disease (Stage III). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44711?source=see_link\">",
"     \"Adjuvant immunotherapy for melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26664?source=see_link\">",
"     \"Evaluation and treatment of regional lymph nodes in melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, not all of these patients may have had true hematogenous spread of their disease. Taking all these factors into account, it is probably the rare patient with truly distant metastatic melanoma who will be cured of skin, subcutaneous, or lymph node disease with surgery alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Lung",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent cause of death from metastatic melanoma is either respiratory failure or intracranial metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Surgical treatment of metastatic disease in these sites may be effective at relieving symptoms, even though survival may not be enhanced.",
"   </p>",
"   <p>",
"    The results from two large reports illustrate the outcomes for patients undergoing resection of lung metastases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Data from the International Registry of Lung Metastases defined parameters associated with a better prognosis following resection [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/11\">",
"       11",
"      </a>",
"      ]. The five- and ten-year survival rates in 282 patients were 22 and 16 percent after complete metastasectomy, while there were no long-term survivors after incomplete resection (n = 46). Poor prognostic factors included a metastasis-free interval less than 36 months and the presence of multiple lung metastases. Patients without these risk factors had the best five-year survival, followed by those with one and two risk factors (29, 20, and 7 percent, respectively).",
"     </li>",
"     <li>",
"      Factors affecting prognosis were analyzed in a single institution series of 318 patients who underwent metastasectomy for lung metastases over a 34 year period [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/12\">",
"       12",
"      </a>",
"      ]. Risk factors associated with a poorer prognosis in multivariate analysis included the presence of two or more metastases, a disease-free interval less than five years, the presence of extrathoracic disease, or nodular histology. For patients with none of these risk factors, the median survival was 14 months and the five-year survival was 26 percent. In contrast, patients with three or more risk factors had a median survival of five months and a 2 percent five-year survival.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When surgery is being considered, conservative lung resections should be performed so as not to compromise options for subsequent systemic therapy. In addition, a second recurrence of metastatic disease is likely, which may further deplete functioning lung parenchyma.",
"   </p>",
"   <p>",
"    The use of preoperative PET scanning to improve the selection of patients for pulmonary metastasectomy is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15450?source=see_link&amp;anchor=H4#H4\">",
"     \"Imaging studies in melanoma\", section on 'PET/CT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Brain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain metastases may be associated with a variety of neurologic symptoms or deficits, depending upon their anatomic location, or they may be detected incidentally on screening imaging. Intracranial metastases are usually multiple, but can be solitary in 25 to 40 percent of patients. Brain metastases are associated with a poor prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39927?source=see_link\">",
"     \"Management of brain metastases in melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39927?source=see_link&amp;anchor=H3#H3\">",
"     \"Management of brain metastases in melanoma\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical resection may provide effective palliation, prevent intracerebral hemorrhage, and is the treatment of choice for patients with accessible solitary intracranial metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with multiple accessible lesions may have a prognosis similar to those with a solitary metastasis if all metastases can be completely resected, and surgical resection should be considered whenever possible. Surgical resection should be considered as an option whenever possible, although stereotactic radiosurgical approaches are often preferred for surgically inaccessible lesions or when multiple lesions are present.",
"   </p>",
"   <p>",
"    The management of brain metastases in patients with metastatic melanoma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39927?source=see_link\">",
"     \"Management of brain metastases in melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/35/44601?source=see_link\">",
"     \"Treatment of brain metastases in favorable prognosis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gastrointestinal tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic melanoma involving the gastrointestinal tract may present with anemia, overt bleeding, pain, obstruction, or intussusception [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/14\">",
"     14",
"    </a>",
"    ]. The jejunum and ileum are the most commonly involved sites, followed by the colon, rectum, and stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/9\">",
"     9",
"    </a>",
"    ]. Surgery is usually reserved for patients with the above complications.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, 135 patients treated surgically for abdominal metastases from melanoma had a median survival of 11 months, significantly longer than the survival of patients treated medically [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/15\">",
"       15",
"      </a>",
"      ]. Tumor extirpation was associated with a 10 month symptom-free survival, again significantly longer than that achieved by nonsurgical approaches. Complete resection was possible in one-third of patients.",
"     </li>",
"     <li>",
"      In four other studies with a combined experience of over 200 patients, the presenting symptom was relieved in 90 to 95 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/14,16-18\">",
"       14,16-18",
"      </a>",
"      ]. The median survival ranged from 8 to 13 months with a five-year survival of 10 to 18 percent. In the smaller subset of patients with successful complete resection, median survival ranged from 15 to 44 months with five-year survivals of up to 38 to 45 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In these studies, however, the patients selected for surgery were those who were more likely to be resectable than those who were selected for nonsurgical therapies. Similarly, patients selected for surgery are often in better general health than those who receive nonsurgical therapy. Nevertheless, resection is a reasonable option for a subset of symptomatic patients with good performance status and no other sites of metastatic disease; such patients may achieve good palliation and perhaps long-term survival. Major resections, such as gastrectomy or abdominoperineal resection, should be avoided, as metastases in these sites are less likely to be symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection is rarely indicated for melanoma involving the spine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/19\">",
"     19",
"    </a>",
"    ]. Hepatic resection is sometimes successful for isolated liver metastases from primary sites outside the gastrointestinal tract, including melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. In general, however, liver metastases from cutaneous melanoma are rarely resectable for cure, median time to recurrence is quite short (&lt;6 months), and the prognosis is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Resection of metastases to endocrine organs may provide palliation and prolong survival for symptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In one report, 18 of 27 patients (67 percent) with adrenal metastases from melanoma were rendered disease-free surgically; the median survival was 26 months following complete resection compared to nine months after palliative resection. Laparoscopic adrenalectomy for metastatic disease is safe, effective, and associated with less morbidity than the open approach [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Second recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who successfully undergo complete resection of metastatic disease remain at high risk of a second recurrence. Further surgery may permit long-term disease-free survival in some of these patients. In a single institution series of 211 patients with metastatic melanoma who were surgically rendered free of disease, 62 percent developed a second recurrence, and the median recurrence-free interval was eight months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2183/abstract/28\">",
"     28",
"    </a>",
"    ]. Eight of 40 patients (20 percent) who underwent a second complete surgical metastasectomy remained free of disease at five years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=see_link\">",
"       \"Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/8/39042?source=see_link\">",
"       \"Patient information: Melanoma treatment; advanced or metastatic melanoma (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical metastasectomy may have a role in carefully selected patients who have limited sites of metastatic disease, either when they initially present with metastatic disease or if they have had a high quality response to immunotherapy or potentially molecularly targeted therapy. Although widespread metastatic disease usually develops in most cases, complete resection of metastatic disease is associated with prolonged (five-year) survival in up to 40 percent of cases. Resection should be reserved for the relief or prevention of morbidity due to local tumor growth and for patients in whom a longer survival might be expected with surgical rather than medical treatment. (See",
"      <a class=\"local\" href=\"#H434153966\">",
"       'Rationale'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Criteria for surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following initial treatment for cutaneous melanoma, routine monitoring of asymptomatic patients should focus on those sites most likely to harbor metastatic disease. A careful history and examination of the skin, soft tissues, and all lymph node basins should be routinely performed. In addition, periodic (at least annual) chest x-ray and serum LDH should be performed. If new symptoms, physical findings, chest x-ray or blood test abnormalities suggesting disease recurrence are detected, imaging studies (MRI, CT, PET) are required to document recurrence and define the extent of disease if metastasectomy is being considered. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic, easily resected metastases are also appropriately resected even in patients with multiple other sites of disease. For patients whose life is limited, surgical treatment often provides the quickest and possibly the most durable palliation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Surgical management of specific metastatic sites'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/1\">",
"      Cole BF, Gelber RD, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 1996; 14:2666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/2\">",
"      Sosman JA, Moon J, Tuthill RJ, et al. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer 2011; 117:4740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/3\">",
"      Hsueh EC, Essner R, Foshag LJ, et al. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 2002; 20:4549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/4\">",
"      Yang JC, Abad J, Sherry R. Treatment of oligometastases after successful immunotherapy. Semin Radiat Oncol 2006; 16:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/5\">",
"      Karakousis CP, Velez A, Driscoll DL, Takita H. Metastasectomy in malignant melanoma. Surgery 1994; 115:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/6\">",
"      Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000; 87:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/7\">",
"      Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 1999; 6:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/8\">",
"      Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978; 135:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/9\">",
"      DASGUPTA T, BRASFIELD R. METASTATIC MELANOMA. A CLINICOPATHOLOGICAL STUDY. Cancer 1964; 17:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/10\">",
"      Budman DR, Camacho E, Wittes RE. The current causes of death in patients with malignant melanoma. Eur J Cancer 1978; 14:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/11\">",
"      Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer 2000; 83:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/12\">",
"      Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007; 133:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/13\">",
"      Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/14\">",
"      Branum GD, Seigler HF. Role of surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg 1991; 162:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/15\">",
"      Gutman H, Hess KR, Kokotsakis JA, et al. Surgery for abdominal metastases of cutaneous melanoma. World J Surg 2001; 25:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/16\">",
"      Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 1999; 6:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/17\">",
"      Krige JE, Nel PN, Hudson DA. Surgical treatment of metastatic melanoma of the small bowel. Am Surg 1996; 62:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/18\">",
"      Caputy GG, Donohue JH, Goellner JR, Weaver AL. Metastatic melanoma of the gastrointestinal tract. Results of surgical management. Arch Surg 1991; 126:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/19\">",
"      Weigel B, Maghsudi M, Neumann C, et al. Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine (Phila Pa 1976) 1999; 24:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/20\">",
"      Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000; 6:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/21\">",
"      Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000; 89:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/22\">",
"      Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006; 13:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/23\">",
"      Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 2006; 244:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/24\">",
"      DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006; 13:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/25\">",
"      Branum GD, Epstein RE, Leight GS, Seigler HF. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery 1991; 109:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/26\">",
"      Haigh PI, Essner R, Wardlaw JC, et al. Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol 1999; 6:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/27\">",
"      Strong VE, D'Angelica M, Tang L, et al. Laparoscopic adrenalectomy for isolated adrenal metastasis. Ann Surg Oncol 2007; 14:3392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2183/abstract/28\">",
"      Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999; 71:209.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7622 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-210.101.131.232-895BD5A23F-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2183=[""].join("\n");
var outline_f2_8_2183=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H434153966\">",
"      RATIONALE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CRITERIA FOR SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H434154051\">",
"      INTEGRATION OF SURGERY WITH SYSTEMIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SURGICAL MANAGEMENT OF SPECIFIC METASTATIC SITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Skin, subcutaneous tissue, and lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Lung",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Brain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Second recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44711?source=related_link\">",
"      Adjuvant immunotherapy for melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/28/2506?source=related_link\">",
"      Advanced melanoma: anti-CTLA-4 antibodies and other immune checkpoint strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/28/27081?source=related_link\">",
"      Cutaneous melanoma: Management of in transit metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34007?source=related_link\">",
"      Cutaneous melanoma: Management of local recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26664?source=related_link\">",
"      Evaluation and treatment of regional lymph nodes in melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15450?source=related_link\">",
"      Imaging studies in melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26585?source=related_link\">",
"      Initial surgical management of melanoma of the skin and unusual sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=related_link\">",
"      Interleukin-2 and other immunotherapies for advanced melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39927?source=related_link\">",
"      Management of brain metastases in melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=related_link\">",
"      Molecularly targeted therapy for metastatic melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15558?source=related_link\">",
"      Overview of the management of advanced melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/8/39042?source=related_link\">",
"      Patient information: Melanoma treatment; advanced or metastatic melanoma (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=related_link\">",
"      Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35065?source=related_link\">",
"      Staging work-up and surveillance after treatment of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/35/44601?source=related_link\">",
"      Treatment of brain metastases in favorable prognosis patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_8_2184="PVOD septal thickening";
var content_f2_8_2184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Longitudinal section of lobular septa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arrows demonstrate septal thickening due to interstitial edema and fibrosis. Hematoxylin-eosin; original magnification: x4.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mandel, J, Mark, E, Hales, C. Pulmonary veno- occlusive disease. Am J Respir Crit Care Med 2000; 162:1964. Official Journal of the American Thoracic Society &copy; American Lung Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2184=[""].join("\n");
var outline_f2_8_2184=null;
var title_f2_8_2185="Mucinous adenocarcinoma in situ";
var content_f2_8_2185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucinous adenocarcinoma in situ",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 538px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) This mucinous tumor consists of a nodular proliferation of mucinous columnar cells growing in a purely lepidic pattern. Although there is a small central scar, no stromal or vascular invasion is seen.",
"    <br>",
"     (B) The tumor consists of cuboidal to columnar cells with abundant apical mucin and small basally oriented nuclei.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6:244. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2185=[""].join("\n");
var outline_f2_8_2185=null;
var title_f2_8_2186="Management of skin cancer in solid organ transplant recipients";
var content_f2_8_2186=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of skin cancer in solid organ transplant recipients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Thomas Stasko, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Allison M Hanlon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2186/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/8/2186/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/8/2186/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H2295753\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solid organ transplant recipients are at increased risk for cutaneous malignancies, a finding related to the long-term use of immunosuppression. Because some skin cancers demonstrate aggressive biologic behavior in the setting of immunosuppression, care must be taken to identify and treat early lesions appropriately. In addition to treatments that directly target cutaneous malignancies, modulation of immunosuppression and preventive measures often play an important role in the management of these patients. Organ transplant recipients with a history of skin cancer should be followed closely for the development of new lesions, locally recurrent lesions, and metastatic disease.",
"   </p>",
"   <p>",
"    The management of skin cancers in organ transplant recipients will be reviewed here. The epidemiology and risk factors for skin cancers in organ transplant recipients, as well as a summary of other malignancies that develop with increased frequency after solid organ transplantation, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=see_link\">",
"     \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294558\">",
"    <span class=\"h1\">",
"     SQUAMOUS CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Squamous cell is carcinoma (SCC) is the most common cutaneous malignancy in solid organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. As in the immunocompetent population, cutaneous SCC is most likely to occur in patients with fair skin [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=see_link\">",
"     \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison to SCC in immunocompetent patients, SCC in organ transplant recipients is more likely to manifest as aggressive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/7\">",
"     7",
"    </a>",
"    ]. The prognosis is poor for the 5 to 8 percent of patients who develop metastases (",
"    <a class=\"graphic graphic_picture graphicRef60608 \" href=\"UTD.htm?25/23/25970\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]; in a retrospective study that included 58 organ transplant recipients with distant or systemic metastases of cutaneous SCC, the three-year disease-specific survival rate was 29 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, once detected, prompt, appropriate management of early SCC is essential [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/7,9\">",
"     7,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294565\">",
"    <span class=\"h2\">",
"     Patient evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;All lesions that are suspicious for SCC should be pathologically examined to confirm the diagnosis and to evaluate for features associated with aggressive disease (see",
"    <a class=\"local\" href=\"#H2294572\">",
"     'Lesion management'",
"    </a>",
"    below). Biopsies of papular or nodular lesions should extend at least into the deep reticular dermis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who are determined to have cutaneous SCC should undergo a complete skin examination and palpation of draining lymph nodes. The need for additional laboratory or radiologic evaluation is based upon the detection of findings that suggest locoregional or metastatic spread of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/45/15063?source=see_link\">",
"     \"Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294572\">",
"    <span class=\"h2\">",
"     Lesion management",
"    </span>",
"    &nbsp;&mdash;&nbsp;In immunocompetent patients, a combination of clinical and histopathological features is used to classify individual SCCs as low-risk or high-risk for aggressive clinical behavior. These classifications are used to guide the approach to treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21226?source=see_link\">",
"     \"Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon the increased likelihood for aggressive disease, invasive SCCs in organ transplant recipients are generally considered high-risk lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/10\">",
"     10",
"    </a>",
"    ]. Thus, procedures that provide pathological confirmation of tumor removal, such as Mohs surgery or conventional surgical excision, are the preferred treatments for invasive SCCs in these patients. Destructive measures such as electrodesiccation and curettage (ED&amp;C) do",
"    <strong>",
"     not",
"    </strong>",
"    provide pathological confirmation of lesion removal and are primarily reserved for SCC in situ or carefully selected invasive lesions that lack additional high-risk features.",
"   </p>",
"   <p>",
"    Additional high-risk features of SCC include [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Large size (&ge;6 mm on eyebrows, eyelids, periocular skin, central face, temple, nose, lips, chin, mandible, periauricular or postauricular areas, ears, genitalia, hands, or feet; &ge;10 mm on scalp, forehead, cheeks, or neck; &ge;20 mm on trunk or extremities)",
"     </li>",
"     <li>",
"      Indistinct borders",
"     </li>",
"     <li>",
"      Rapid growth",
"     </li>",
"     <li>",
"      Recurrent lesion",
"     </li>",
"     <li>",
"      Lesion in site of chronic inflammation or prior radiation therapy",
"     </li>",
"     <li>",
"      Neurologic symptoms",
"     </li>",
"     <li>",
"      Aggressive histopathologic features (moderately or poorly differentiated, Clark level &ge;IV, lesion thickness &ge;4 mm, perineural involvement, vascular involvement)",
"     </li>",
"     <li>",
"      Adenoid (acantholytic), adenosquamous, or desmoplastic histopathologic subtypes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294586\">",
"    <span class=\"h3\">",
"     Invasive lesions without additional high-risk features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common treatments for SCCs in organ transplant recipients that lack other features of aggressive disease (eg, small, well-differentiated lesions in low-risk sites) include surgical excision and electrodesiccation and curettage (ED&amp;C).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2296221\">",
"    <span class=\"h4\">",
"     Surgical excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;SCCs without additional high-risk features are frequently managed with conventional surgical excision. Lesions should be excised with a margin of tissue that extends 4 to 6 mm beyond the peripheral edge of erythema, and the specimen should be sent for postoperative pathological margin assessment. Mohs surgery, a tissue-preserving, specialized surgical procedure that is used to evaluate 100 percent of the tissue margins, is generally not necessary. However, Mohs surgery may be appropriate in cases where tissue conservation is desired. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link\">",
"     \"Mohs surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2296228\">",
"    <span class=\"h4\">",
"     Electrodesiccation and curettage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrodesiccation and curettage (ED&amp;C), a procedure that involves three cycles of scraping of the tumor with a curette followed by electrodesiccation, is an alternative treatment for lower risk lesions. The efficacy of ED&amp;C for SCC in organ transplant recipients is supported by the results of a retrospective study of 211 SCCs in 48 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/11\">",
"     11",
"    </a>",
"    ]. After a mean follow-up period of 50 months, residual or recurrent SCC occurred in only 6 percent. The procedure results in a hypopigmented oval scar, and is generally reserved for lesions in non-cosmetically sensitive sites, such as the trunk and extremities (excluding hands and feet). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Electrosurgery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=see_link&amp;anchor=H23#H23\">",
"     \"Dermatologic procedures\", section on 'Curettage and electrodesiccation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Advantages of ED&amp;C are that the procedure is quick, generally well-tolerated, and less expensive than excisional surgery. The rapid nature of the procedure can facilitate the treatment of patients who repetitively develop new lesions.",
"   </p>",
"   <p>",
"    The main disadvantage of ED&amp;C is the lack of histological margin control, which underlies the importance of carefully selecting lesions for treatment. Treatment should",
"    <strong>",
"     not",
"    </strong>",
"    be performed in hair-bearing areas because the presence of terminal hair follicles may reduce the efficacy of the procedure. In addition, ED&amp;C cannot reliably eradicate lesions that extend into the subcutaneous fat. If fat is reached during the curettage stage, ED&amp;C should be abandoned and the tumor should be removed surgically.",
"   </p>",
"   <p>",
"    Some clinicians choose to perform ED&amp;C at the time of biopsy on lesions that are clinically consistent with small, well-differentiated SCCs. If pathology results demonstrate aggressive histopathological features, subsequent surgical excision should be performed to ensure adequate tumor removal.",
"   </p>",
"   <p>",
"    All sites treated with ED&amp;C should be followed closely for lesion recurrence. We typically follow such patients at three to six month intervals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2296243\">",
"    <span class=\"h4\">",
"     Cryosurgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryosurgery is infrequently used for the management of low-risk SCC in immunocompetent patients because of the difficulty in obtaining the requisite temperatures for tumor destruction in a uniform manner and the significant tissue edema and drainage that follow the procedure. In addition, recurrent disease is sometimes difficult to detect in the resulting scar. We typically do",
"    <strong>",
"     not",
"    </strong>",
"    use cryosurgery for the treatment of SCC in organ transplant recipients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Cryotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2296293\">",
"    <span class=\"h3\">",
"     Invasive lesions with additional high-risk features",
"    </span>",
"    &nbsp;&mdash;&nbsp;SCCs in immunosuppressed patients that demonstrate other high-risk features (eg, large size, poor differentiation, high-risk site) should be managed with techniques that provide pathological confirmation of tumor removal (see",
"    <a class=\"local\" href=\"#H2294572\">",
"     'Lesion management'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Mohs surgery is our preferred treatment for SCCs in such patients. Mohs surgery is a tissue-sparing surgical technique that provides evaluation of 100 percent of the margins of excised tissue. Although reported cure rates for Mohs surgery for SCC exceed those for other treatment modalities (five-year cure rates of greater than 96 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/12,13\">",
"     12,13",
"    </a>",
"    ], there have been no randomized trials comparing the efficacy of Mohs surgery to other therapies for SCC. One retrospective study that evaluated the efficacy of Mohs surgery for 260 high-risk SCCs in 215 patients (20 percent of whom were immunosuppressed) found local recurrences of only three lesions (1.2 percent) at a mean follow-up of 3.9 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/14\">",
"     14",
"    </a>",
"    ]. Six tumors metastasized (2.3 percent), resulting in one fatality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link\">",
"     \"Mohs surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, Mohs surgery is expensive, time-consuming, and not universally available. If Mohs surgery cannot be performed, surgical excision with intraoperative frozen sections may be used to remove aggressive lesions. If neither technique is available and tissue conservation is not a concern, conventional surgical excision with postoperative margin examination may be used. Lesions treated with conventional surgical excision should be excised with at least 6 to 10 mm margins beyond the edge of erythema [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/9\">",
"     9",
"    </a>",
"    ]. Guidelines from the National Comprehensive Cancer Network state that lesions &ge;20 mm on the trunk or extremities should be excised with 10 mm margins [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As in immunocompetent patients, the role of sentinel lymph node biopsy for SCC in organ transplant recipients remains uncertain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/45/15063?source=see_link&amp;anchor=H2824518#H2824518\">",
"     \"Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma\", section on 'Sentinel lymph node biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2296349\">",
"    <span class=\"h3\">",
"     SCC in situ (Bowen's disease)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Options for the treatment of SCC in situ are similar to those in immunocompetent patients. Frequently employed therapies include surgical excision, electrodesiccation and curettage, and topical chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/15\">",
"     15",
"    </a>",
"    ]. The results of small randomized trials suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    , a topical immunomodulating agent, can be used safely in organ transplant recipients when applied to limited areas (60 or 100 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2294677\">",
"     'Actinic keratoses'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Low-risk lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H784603\">",
"    <span class=\"h3\">",
"     Indications for radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation can be used to treat SCCs in patients who are unable to tolerate surgery. Radiation also is used as an adjunctive therapy for lesions that cannot be completely excised or that demonstrate substantial perineural involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/9\">",
"     9",
"    </a>",
"    ]. A disadvantage of radiation therapy is an increased risk for the future development of skin cancer in treated sites [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21226?source=see_link&amp;anchor=H90084858#H90084858\">",
"     \"Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma\", section on 'Radiation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/56/25482?source=see_link&amp;anchor=H10#H10\">",
"     \"Epidemiology and risk factors for cutaneous squamous cell carcinoma\", section on 'Ionizing radiation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\", section on 'Ionizing radiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294600\">",
"    <span class=\"h2\">",
"     Severe or metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of organ transplant patients with life-threatening, metastatic disease is challenging. Metastatic disease has responded to systemic therapies such as platinum-based chemotherapeutic agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/19\">",
"     19",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Fatal diffuse alveolar damage has been reported in two lung transplant patients treated with cetuximab for metastatic cutaneous SCC, which raises concern about its use in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14293?source=see_link\">",
"     \"Systemic treatment of advanced cutaneous squamous and basal cell carcinomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294607\">",
"    <span class=\"h3\">",
"     Modulation of immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because increased intensity and duration of immunosuppression appear to promote the development of cutaneous malignancies in organ transplant recipients, reduction of immunosuppression is considered in patients who develop numerous lesions, recurrent disease, or metastatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/3,23-27\">",
"     3,23-27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=see_link&amp;anchor=H442687#H442687\">",
"     \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No randomized trials have evaluated the effect of reduction in immunosuppression in organ transplant recipients with multiple, recurrent, or aggressive SCC. Data that suggest that reduction of immunosuppression may be of benefit include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a randomized trial of 231 renal transplant recipients, treatment with normal doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      versus low doses of these agents resulted in significantly fewer patients with squamous cell or basal cell cancers in the low-dose group (14.7 versus 22.6 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/24\">",
"       24",
"      </a>",
"      ]. Low-dose therapy was associated with a higher rate of graft rejection (7.8 versus 0.9 percent), but graft survival rates were similar.",
"     </li>",
"     <li>",
"      In a series of six organ transplant recipients with a history of multiple post-transplantation SCCs, cessation of immunosuppressive therapy was associated with reductions in skin cancer development in four [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/25\">",
"       25",
"      </a>",
"      ]. One patient who improved after cessation of immunosuppression had recurrence of new skin cancers after retransplantation and reinitiation of immunosuppressive therapy.",
"     </li>",
"     <li>",
"      In a retrospective study of nine renal transplant recipients with deeply invasive SCC",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      regional metastatic disease (involving adjacent soft tissues or lymph nodes), those patients in whom immunosuppression was reduced or discontinued had a significantly longer duration of survival free of distant metastatic disease compared with patients whose immunosuppression was unchanged [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because reductions in immunosuppression can increase the risk for graft rejection, the risks and benefits of adjusting the level of immunosuppression must be carefully considered on an individual basis. Definitive guidelines have not been established. An expert consensus on the reduction of immunosuppression in organ transplant recipients with skin cancer has been published (",
"    <a class=\"graphic graphic_table graphicRef76140 \" href=\"UTD.htm?16/19/16702\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/27\">",
"     27",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294614\">",
"    <span class=\"h4\">",
"     Mammalian target of rapamycin (mTOR) inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with calcineurin inhibitor-based regimens, immunosuppression with the mTOR inhibitors",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/4/6218?source=see_link\">",
"     everolimus",
"    </a>",
"    may reduce the risk for malignancies, including nonmelanoma skin cancer, in organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/28-36\">",
"     28-36",
"    </a>",
"    ]. Examples of studies that support a benefit of these agents include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a two-year phase 3 randomized trial of 120 renal transplant recipients with a history of at least one SCC, patients who were randomized to have their calcineurin inhibitor replaced with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      had a significant delay in the onset of new SCCs when compared to patients who continued treatment with a calcineurin inhibitor (median interval of 15 versus 7 months) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/36\">",
"       36",
"      </a>",
"      ]. The greatest benefit was seen among patients with a history of only one SCC (hazard ratio [HR] for new SCC 0.03, 95% CI 0-0.91). In contrast, among patients with a history of multiple SCCs the difference in risk for a new SCC was not statistically significant (HR 0.67, 95% CI 0.29-1.54).",
"     </li>",
"     <li>",
"      In a randomized trial of 44 renal transplant recipients in which patients were maintained on their original immunosuppressive regimens (most commonly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      mofetil) or were changed to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      plus prednisone, fewer premalignant skin lesions and nonmelanoma skin cancers developed in patients treated with sirolimus [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/34\">",
"       34",
"      </a>",
"      ]. In the sirolimus group, only one BCC developed; in the control group, five invasive SCCs, one BCC, and two lesions of Bowen&rsquo;s disease were detected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the favorable findings regarding the risk for nonmelanoma skin cancer, the adverse effects of mTOR inhibitors may be a concern. In the first randomized trial described above, 60 patients in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    group versus 14 patients in the calcineurin inhibitor group experienced a serious adverse effect, and adverse effects led to the discontinuation of sirolimus in 15 patients (23 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/36\">",
"     36",
"    </a>",
"    ]. In the second trial, patients in the sirolimus group were more likely than patients in the control group to withdraw from the study due to drug-related adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the high withdrawal rates among patients switched to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    in these trials may not accurately reflect the comparative tolerability of these regimens since patients in the sirolimus groups underwent a change in treatment. In the control groups, patients were maintained on their preexisting treatment regimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294621\">",
"    <span class=\"h2\">",
"     Chemoprevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemopreventive measures are considered for patients who develop multiple (more than five) SCCs per year, aggressive SCCs, or accelerated development of SCCs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/37\">",
"     37",
"    </a>",
"    ]. Medications that have been studied for the prevention of SCC in organ transplant recipients include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294628\">",
"    <span class=\"h3\">",
"     Acitretin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic retinoids such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    , and etretinate (the latter is no longer commercially available) have been used for the prevention of nonmelanoma skin cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/38-42\">",
"     38-42",
"    </a>",
"    ]. Data from two randomized trials support benefit of acitretin:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an open-label, randomized, cross-over trial of 23 organ transplant recipients treated for 12 months with 25",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      or a dose titrated according to patient tolerance, significantly fewer SCCs developed during acitretin therapy than during the treatment-free period [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/43\">",
"       43",
"      </a>",
"      ]. A nonsignificant trend towards a reduction in BCC was also noted. Nine patients withdrew from the study due to drug-related side effects.",
"     </li>",
"     <li>",
"      In a six-month, randomized trial of 44 renal transplant patients treated with 30",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      or placebo, significantly fewer skin cancers developed in patients treated with acitretin [",
"      <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/44\">",
"       44",
"      </a>",
"      ]. The majority of skin cancers detected (17 out of 20) were SCCs; new SCCs developed in 11 versus 47 percent of patients in the respective groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, a randomized dose-comparison trial in renal transplant recipients found no benefit of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    0.2 or 0.4",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    for three months followed by 0.2",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    for nine months in the prevention of skin cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/45\">",
"     45",
"    </a>",
"    ]. Although actinic keratoses decreased by 50 percent with treatment in both groups, the numbers of new SCCs, BCCs, and keratoacanthomas were similar in the pre-treatment and post-treatment periods. The majority of patients did not tolerate the dose of 0.4",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    and required early dose reductions.",
"   </p>",
"   <p>",
"    The major side effects of systemic retinoids include teratogenicity, dryness of the eyes, nose, lips, mouth, and skin (",
"    <a class=\"graphic graphic_picture graphicRef82108 \" href=\"UTD.htm?7/38/7778\">",
"     picture 2",
"    </a>",
"    ), abnormalities in liver function tests, and hyperlipidemia. Periodic laboratory monitoring is necessary (",
"    <a class=\"graphic graphic_picture graphicRef82108 \" href=\"UTD.htm?7/38/7778\">",
"     picture 2",
"    </a>",
"    ) (see",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     \"Acitretin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     \"Isotretinoin: Drug information\"",
"    </a>",
"    ). Since pregnancy must be avoided for three years after the discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    , treatment usually is not given to women of childbearing potential. Contraception is required for only one month after the completion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    ; however, evidence for the efficacy of this agent for chemoprevention in organ transplant recipients is limited to a case report in which a patient improved with 0.5",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     Acitretin",
"    </a>",
"    should be started at low doses to facilitate tolerance of adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/37\">",
"     37",
"    </a>",
"    ]. We typically begin with 10 mg every day or every other day, increase to 20 mg daily after the first month of therapy, and adjust per patient tolerance thereafter. We treat most patients with final doses ranging between 25 mg per day and alternating doses of 10 and 20 mg per day [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    is temporary; lesion development recurs after cessation of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Further studies are necessary to determine the long term safety, efficacy, and optimal treatment regimen for acitretin as a chemopreventive agent in organ transplant recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294635\">",
"    <span class=\"h3\">",
"     Capecitabine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     Capecitabine",
"    </a>",
"    is a chemotherapeutic agent that halted the development of new cutaneous carcinomas and improved existing lesions in a series of three transplant patients with histories of multiple SCCs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/19\">",
"     19",
"    </a>",
"    ]. Additional studies are necessary to determine the efficacy and safety of capecitabine in this setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294642\">",
"    <span class=\"h3\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional agents that have been studied for the prevention of SCC in other populations are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/56/25482?source=see_link&amp;anchor=H31#H31\">",
"     \"Epidemiology and risk factors for cutaneous squamous cell carcinoma\", section on 'Chemoprevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294649\">",
"    <span class=\"h1\">",
"     BASAL CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basal cell carcinoma (BCC) is not associated with the same level of morbidity and mortality as SCC in organ transplant recipients. The management of BCC in this population resembles management in the immunocompetent patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"     \"Treatment and prognosis of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=see_link\">",
"     \"Treatment of basal cell carcinomas at high risk for recurrence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     Imiquimod",
"    </a>",
"    is a topical immunostimulatory agent that is sometimes used for the treatment of superficial BCC. The use of imiquimod for limited periods on small areas (60 or 100 mm",
"    <sup>",
"     2",
"    </sup>",
"    ) appears to be safe in organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2294677\">",
"     'Actinic keratoses'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Imiquimod'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294663\">",
"    <span class=\"h1\">",
"     MELANOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of melanoma in organ transplant recipients usually parallels the care of melanoma in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/47\">",
"     47",
"    </a>",
"    ]. Patients with early stage melanoma frequently can be managed with surgical excision; sentinel lymph node biopsy is indicated for lesions &gt;1 mm in depth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26585?source=see_link\">",
"     \"Initial surgical management of melanoma of the skin and unusual sites\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of systemic immunomodulatory or molecularly targeted therapies for metastatic melanoma has not been specifically studied in the organ transplant population. Immunostimulatory therapies such as interferon are generally considered unfavorable due to the possibility of graft rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=see_link\">",
"     \"Interleukin-2 and other immunotherapies for advanced melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=see_link\">",
"     \"Molecularly targeted therapy for metastatic melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2297024\">",
"    <span class=\"h2\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate management of immunosuppression in patients diagnosed with melanoma has not been definitively determined. In general, immunosuppression should be reduced to the minimal regimen necessary to maintain organ tolerance (",
"    <a class=\"graphic graphic_table graphicRef76140 \" href=\"UTD.htm?16/19/16702\">",
"     table 1",
"    </a>",
"    ). Greater reduction in immunosuppression can be considered in advanced cases, if the benefits of doing so are perceived to exceed the risks associated with rejection of the transplanted organ.",
"   </p>",
"   <p>",
"    Immunosuppression with rapamycin has been associated with a reduced risk of malignancy in organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/28,49\">",
"     28,49",
"    </a>",
"    ]. However, the specific impact of rapamycin in patients who develop melanoma after organ transplantation is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2297017\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although limited prognostic data are available on patients who develop melanoma following organ transplantation, the results of a few studies suggest that while organ transplant recipients with thin melanomas may have survival rates that are comparable to patients in the general population, those with thicker lesions may have worse prognoses [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/47,50,51\">",
"     47,50,51",
"    </a>",
"    ]. The largest study is a retrospective review of records from 638 patients with 724 post-transplantation melanomas that compared three-year survival rates in this population to survival data on melanoma patients from the Surveillance, Epidemiology, and End Results (SEER) Program [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/50\">",
"     50",
"    </a>",
"    ]. Data on Breslow thickness (classified as &le;0.75, 0.76 to 1.50, 1.51 to 3.00, and &gt;3.00 mm) or Clark level (I to V) were available for 123 and 175 organ transplant recipients, respectively. When Breslow depth and Clark level were taken into account, melanoma-specific survival rates were lower than expected among organ transplant recipients with lesions that were 1.51 to 3.00 mm thick or classified as Clark level III or IV. Survival rates were not significantly different from SEER data for the other lesion thickness, Clark level I, or Clark level II groups. Moreover, a separate retrospective review that included 91 post-transplantation melanomas found that although disease outcomes were comparable to the general population for T1 or T2 tumors (&le; 2 mm thick), the prognosis was significantly worse for T3 or T4 tumors (&gt;2 mm thick) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42488?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system and other prognostic factors in cutaneous melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data on the prognosis of patients with melanoma prior to organ transplantation also are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/47,50,52\">",
"     47,50,52",
"    </a>",
"    ]. An analysis of the data from two retrospective studies with a total of 17 patients who had invasive melanoma prior to organ transplantation (median depth 1 mm, range 0.35 mm to 18 mm) found no disease recurrences or disease-related deaths after organ transplantation within a median follow-up period of 5.5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/47\">",
"     47",
"    </a>",
"    ]. Of note, the majority of patients were transplanted more than two years after treatment of their melanomas. In contrast, recurrences of pretransplant melanoma were reported in 6 out of 31 patients in another retrospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/52\">",
"     52",
"    </a>",
"    ]. The six patients died an average of 16 months after organ transplantation (range 6 to 30 months).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294670\">",
"    <span class=\"h1\">",
"     KAPOSI SARCOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reducing the level of immunosuppression is the primary therapy for Kaposi&rsquo;s sarcoma in organ transplant recipients (",
"    <a class=\"graphic graphic_table graphicRef76140 \" href=\"UTD.htm?16/19/16702\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/23,53\">",
"     23,53",
"    </a>",
"    ]. In addition, regression of Kaposi&rsquo;s sarcoma has been reported in renal transplant patients after a change in immunosuppressive medication from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. Local and systemic therapies may also be used in the management of these patients. (See",
"    <a class=\"local\" href=\"#H2294614\">",
"     'Mammalian target of rapamycin (mTOR) inhibitors'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link&amp;anchor=H47#H47\">",
"     \"Development of malignancy following solid organ transplantation\", section on 'Kaposi's sarcoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2295682\">",
"    <span class=\"h1\">",
"     MERKEL CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific guidelines exist for the management of Merkel cell carcinoma in organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Surgical excision is the treatment of choice; radiation is used as an adjuvant therapy in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/58\">",
"     58",
"    </a>",
"    ]. Reductions in immunosuppressive regimens have been reported to lead to temporary and partial regression of Merkel cell carcinoma in a few patients (",
"    <a class=\"graphic graphic_table graphicRef76140 \" href=\"UTD.htm?16/19/16702\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Additional studies are necessary to determine the best approach to treatment in organ transplant recipients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link\">",
"     \"Staging and treatment of Merkel cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Merkel cell carcinoma in transplant recipients tends to have a more aggressive course than in immunocompetent patients; approximately 70 percent of patients develop lymph node involvement, and the mortality rate at two years is estimated to be 56 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/59\">",
"     59",
"    </a>",
"    ]. Therefore, patients should be followed closely for the development of metastatic disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link&amp;anchor=H16#H16\">",
"     \"Staging and treatment of Merkel cell carcinoma\", section on 'Prognosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link&amp;anchor=H17#H17\">",
"     \"Staging and treatment of Merkel cell carcinoma\", section on 'Follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294677\">",
"    <span class=\"h1\">",
"     ACTINIC KERATOSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinic keratoses occasionally progress to SCC, and the presence of multiple actinic keratoses on photodamaged skin can make it more difficult to detect early SCCs (",
"    <a class=\"graphic graphic_picture graphicRef69827 graphicRef72634 \" href=\"UTD.htm?6/51/6969\">",
"     picture 3A-B",
"    </a>",
"    ). Thus, the treatment of these lesions is an important component of the management of organ transplant recipients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=see_link\">",
"     \"Treatment of actinic keratosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Local destructive therapies such as cryotherapy, electrocautery, curettage, or carbon dioxide laser can be used for the management of individual lesions. Field therapy with topical 5-fluorouracil or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    is an option for patients with numerous lesions. Initially, concerns over the induction of immune activation and subsequent organ rejection with topical imiquimod limited the use of this agent in the transplant population. However, the results of small randomized trials suggest that this agent can be used safely when applied to limited areas (60 or 100 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) three times per week for up to 16 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The management of actinic keratoses is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of actinic keratosis\", section on 'Overview of treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Photodynamic therapy also has been used for the management of actinic keratoses. Studies assessing the efficacy and duration of effect of photodynamic therapy for the prevention of SCC have yielded variable results [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]. Further studies are necessary to explore the utility of this modality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=see_link&amp;anchor=H519985#H519985\">",
"     \"Treatment of actinic keratosis\", section on 'Photodynamic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294684\">",
"    <span class=\"h1\">",
"     FOLLOW-UP AND PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the increased risk for skin cancer in organ transplant recipients, dermatological evaluation and patient counseling on the risk and prevention of skin cancer should be considered prior to organ transplantation. After organ transplantation, patients should continue to have complete skin examinations on a regular basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2087308\">",
"    <span class=\"h2\">",
"     Follow-up regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of visits following transplantation depends upon the patient&rsquo;s risk factors and medical history; definitive guidelines have not been established. We typically utilize the following follow-up schedule:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No history of skin cancer or actinic keratoses &ndash; once yearly",
"     </li>",
"     <li>",
"      History of actinic keratosis or one low-risk nonmelanoma skin cancer",
"      <strong>",
"       &ndash;",
"      </strong>",
"      every six months",
"     </li>",
"     <li>",
"      Multiple nonmelanoma skin cancers or a history of a high-risk SCC &ndash; every three months",
"     </li>",
"     <li>",
"      History of pre-transplant melanoma &ndash; every six months",
"     </li>",
"     <li>",
"      Post-transplant melanoma &ndash; every three months for two years, then at least every six months",
"     </li>",
"     <li>",
"      Rapidly developing tumors, aggressive tumors, or metastatic skin cancer &ndash; every four to six weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examination of the patient should include the palpation of lymph nodes in all patients with a history of skin cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2087249\">",
"    <span class=\"h2\">",
"     Sun protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;At each visit, patients should be counseled on the use of sunscreens, sun protective clothing, and the warning signs of cutaneous malignancy. The daily use of sun protective measures may decrease the incidence of actinic keratoses and SCC in this population. In a non-randomized controlled study of 120 organ transplant recipients, participants using daily sunscreen developed fewer actinic keratoses and SCCs than subjects with intermittent sunscreen use [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/66\">",
"     66",
"    </a>",
"    ]. Despite the small sample size in this study, organ transplant recipients should be strongly encouraged to comply with sun protective measures, including the use of daily sunscreen [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33447?source=see_link\">",
"     \"Selection of sunscreen and sun-protective measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vitamin D deficiency is more likely to occur in patients who engage in strict sun protection. With approval of the patient&rsquo;s transplant team, vitamin D supplementation can be initiated in deficient patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/8/2186/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2295760\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic immunosuppression in organ transplant recipients is associated with a high risk for cutaneous malignancies. Cutaneous squamous cell carcinoma (SCC) is the most common cutaneous malignancy reported. SCC in organ transplant patients is associated with an increased risk for aggressive disease. (See",
"      <a class=\"local\" href=\"#H2295753\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294558\">",
"       'Squamous cell carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All lesions suspicious for SCC in organ transplant patients should be biopsied and sent for pathological evaluation. The treatment of SCCs is based upon the presence or absence of high-risk features. (See",
"      <a class=\"local\" href=\"#H2294565\">",
"       'Patient evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294572\">",
"       'Lesion management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because SCCs in organ transplant recipients are generally considered high-risk lesions, excisional therapies that provide evaluation of histological margins are generally preferred. Electrodesiccation and curettage (ED&amp;C) is an alternative treatment that can be used for the management of SCCs that exhibit no other clinical or histological features of aggressive disease. (See",
"      <a class=\"local\" href=\"#H2294572\">",
"       'Lesion management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294586\">",
"       'Invasive lesions without additional high-risk features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For SCCs in organ transplant recipients that exhibit other high-risk features, we suggest treatment with Mohs surgery due to the high cure rates and tissue-sparing effect of this treatment (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If Mohs surgery is not available, excision with intraoperative frozen sections can be utilized. If neither of these options is feasible, patients can be managed with conventional surgical excision with postoperative margin assessment. (See",
"      <a class=\"local\" href=\"#H2296293\">",
"       'Invasive lesions with additional high-risk features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data are limited on the efficacy and safety of adjusting immunosuppression in organ transplant recipients with SCC. Modulation of immunosuppression is considered for patients with multiple lesions, recurrent lesions, or aggressive or metastatic SCC. (See",
"      <a class=\"local\" href=\"#H2294607\">",
"       'Modulation of immunosuppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Studies suggest that mammalian target of rapamycin inhibitors such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/4/6218?source=see_link\">",
"       everolimus",
"      </a>",
"      may reduce the development of skin cancers in organ transplant recipients; however, the side effect profile of these drugs may limit their usefulness. Additional studies that evaluate the impact of these agents on skin cancer development are necessary. Chemoprevention with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      may also be of benefit in patients who develop multiple or aggressive SCCs. (See",
"      <a class=\"local\" href=\"#H2294614\">",
"       'Mammalian target of rapamycin (mTOR) inhibitors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294621\">",
"       'Chemoprevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Basal cell carcinoma (BCC), melanoma, and Merkel cell carcinoma are managed similarly in organ transplant recipients and immunocompetent patients. Modulation of immunosuppression is the primary treatment for Kaposi&rsquo;s sarcoma in organ transplant recipients. There are no definitive guidelines regarding alteration in immunosuppressive regimens in patients with BCC, melanoma, or Merkel cell carcinoma. The risks and benefits of reduction in immunosuppression should be considered carefully. (See",
"      <a class=\"local\" href=\"#H2294649\">",
"       'Basal cell carcinoma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294663\">",
"       'Melanoma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2294670\">",
"       'Kaposi sarcoma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2295682\">",
"       'Merkel cell carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Organ transplant recipients should be followed closely for the development of skin cancer. We typically perform full skin examinations at least once yearly. More frequent examinations are indicated in patients with a history of actinic keratoses or skin cancer. Daily sun protection should be strongly encouraged. (See",
"      <a class=\"local\" href=\"#H2294684\">",
"       'Follow-up and prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/1\">",
"      Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/2\">",
"      Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine (Baltimore) 2005; 84:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/3\">",
"      Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/4\">",
"      Espa&ntilde;a A, Mart&iacute;nez-Gonz&aacute;lez MA, Garc&iacute;a-Granero M, et al. A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/5\">",
"      Moosa MR, Gralla J. Skin cancer in renal allograft recipients--experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005; 19:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/6\">",
"      Glover MT, Deeks JJ, Raftery MJ, et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/7\">",
"      Martinez JC, Otley CC, Stasko T, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/8\">",
"      Athar M, Walsh SB, Kopelovich L, Elmets CA. Pathogenesis of nonmelanoma skin cancers in organ transplant recipients. Arch Biochem Biophys 2011; 508:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/9\">",
"      Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/10\">",
"      Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010; 8:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/11\">",
"      de Graaf YG, Basdew VR, van Zwan-Kralt N, et al. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation. Br J Dermatol 2006; 154:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/12\">",
"      Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/13\">",
"      Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/14\">",
"      Pugliano-Mauro M, Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010; 36:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/15\">",
"      Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001; 27:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/16\">",
"      Ulrich C, Bichel J, Euvrard S, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007; 157 Suppl 2:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/17\">",
"      Brown VL, Atkins CL, Ghali L, et al. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 2005; 141:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/18\">",
"      Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/19\">",
"      Endrizzi BT, Lee PK. Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. Dermatol Surg 2009; 35:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/20\">",
"      Rubi&oacute; Casadevall J, Gra&ntilde;a-Su&aacute;rez B, Hernandez-Yag&uuml;e X, et al. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab. Eur J Dermatol 2009; 19:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/21\">",
"      Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology 2009; 219:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/22\">",
"      Leard LE, Cho BK, Jones KD, et al. Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab. J Heart Lung Transplant 2007; 26:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/23\">",
"      Otley CC, Maragh SL. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005; 31:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/24\">",
"      Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/25\">",
"      Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/26\">",
"      Moloney FJ, Kelly PO, Kay EW, et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 2004; 30:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/27\">",
"      Otley CC, Berg D, Ulrich C, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006; 154:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/28\">",
"      Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/29\">",
"      Schena FP, Pascoe MD, Alberu J, et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 2009; 87:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/30\">",
"      Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/31\">",
"      Morelon E, Mamzer-Bruneel MF, Peraldi MN, Kreis H. Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrol Dial Transplant 2001; 16:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/32\">",
"      Mathew T, Kreis H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/33\">",
"      Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004; 30:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/34\">",
"      Salgo R, Gossmann J, Sch&ouml;fer H, et al. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 2010; 10:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/35\">",
"      Signorell J, Hunziker T, Martinelli M, et al. Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. Transplant Proc 2010; 42:3871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/36\">",
"      Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/37\">",
"      Otley CC, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006; 32:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/38\">",
"      Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988; 68:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/39\">",
"      Gibson GE, O'Grady A, Kay EW, Murphy GM. Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol 1998; 10:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/40\">",
"      Kelly JW, Sabto J, Gurr FW, Bruce F. Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991; 338:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/41\">",
"      Rook AH, Jaworsky C, Nguyen T, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995; 59:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/42\">",
"      Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 2005; 152:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/43\">",
"      George R, Weightman W, Russ GR, et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002; 43:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/44\">",
"      Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/45\">",
"      de S&eacute;vaux RG, Smit JV, de Jong EM, et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol 2003; 49:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/46\">",
"      Bellman BA, Eaglstein WH, Miller J. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. Transplantation 1996; 61:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/47\">",
"      Zwald FO, Christenson LJ, Billingsley EM, et al. Melanoma in solid organ transplant recipients. Am J Transplant 2010; 10:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/48\">",
"      Greenberg JN, Zwald FO. Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach. Dermatol Clin 2011; 29:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/49\">",
"      Koehl GE, Andrassy J, Guba M, et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 2004; 77:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/50\">",
"      Brewer JD, Christenson LJ, Weaver AL, et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol 2011; 147:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/51\">",
"      Matin RN, Mesher D, Proby CM, et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8:1891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/52\">",
"      Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/53\">",
"      Zmonarski SC, Boraty��ska M, Puziewicz-Zmonarska A, et al. Kaposi's sarcoma in renal transplant recipients. Ann Transplant 2005; 10:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/54\">",
"      Johari Y, Nicholson ML. Complete resolution of oral Kaposi's sarcoma achieved by changing immunosuppression: a case report. Ann R Coll Surg Engl 2010; 92:W45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/55\">",
"      Pranteda G, Feliziani G, Grimaldi M, et al. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient. J Eur Acad Dermatol Venereol 2008; 22:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/56\">",
"      Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/57\">",
"      Campistol JM, Schena FP. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors. Nephrol Dial Transplant 2007; 22 Suppl 1:i17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/58\">",
"      Zhan FQ, Packianathan VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J Natl Compr Canc Netw 2009; 7:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/59\">",
"      Bajetta E, Platania M, Catena L, et al. Merkel cell carcinoma after liver transplantation: a case report. Tumori 2007; 93:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/60\">",
"      Muirhead R, Ritchie DM. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol (R Coll Radiol) 2007; 19:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/61\">",
"      Friedlaender MM, Rubinger D, Rosenbaum E, et al. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 2002; 73:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/62\">",
"      Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/63\">",
"      Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/64\">",
"      de Graaf YG, Kennedy C, Wolterbeek R, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006; 126:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/65\">",
"      Willey A, Mehta S, Lee PK. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010; 36:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/66\">",
"      Ulrich C, J&uuml;rgensen JS, Degen A, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161 Suppl 3:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/67\">",
"      Mihalis EL, Wysong A, Boscardin WJ, et al. Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients. Br J Dermatol 2013; 168:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/8/2186/abstract/68\">",
"      Reichrath J. Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR). J Photochem Photobiol B 2010; 101:150.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16339 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-B1A854215F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2186=[""].join("\n");
var outline_f2_8_2186=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2295760\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2295753\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294558\">",
"      SQUAMOUS CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294565\">",
"      Patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294572\">",
"      Lesion management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2294586\">",
"      - Invasive lesions without additional high-risk features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2296221\">",
"      Surgical excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2296228\">",
"      Electrodesiccation and curettage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2296243\">",
"      Cryosurgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2296293\">",
"      - Invasive lesions with additional high-risk features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2296349\">",
"      - SCC in situ (Bowen's disease)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H784603\">",
"      - Indications for radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294600\">",
"      Severe or metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2294607\">",
"      - Modulation of immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2294614\">",
"      Mammalian target of rapamycin (mTOR) inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294621\">",
"      Chemoprevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2294628\">",
"      - Acitretin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2294635\">",
"      - Capecitabine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2294642\">",
"      - Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294649\">",
"      BASAL CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294663\">",
"      MELANOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2297024\">",
"      Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2297017\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294670\">",
"      KAPOSI SARCOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2295682\">",
"      MERKEL CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294677\">",
"      ACTINIC KERATOSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294684\">",
"      FOLLOW-UP AND PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2087308\">",
"      Follow-up regimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2087249\">",
"      Sun protection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2295760\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/16339\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16339|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/23/25970\" title=\"picture 1\">",
"      Skin metastasis of squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/38/7778\" title=\"picture 2\">",
"      Acitretin xerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/29/41428\" title=\"picture 3A\">",
"      Actinic damage renal transplant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/61/37843\" title=\"picture 3B\">",
"      Multiple actinic keratoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16339|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/19/16702\" title=\"table 1\">",
"      Management of immunosuppression in skin cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=related_link\">",
"      Acitretin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=related_link\">",
"      Dermatologic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/56/25482?source=related_link\">",
"      Epidemiology and risk factors for cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=related_link\">",
"      Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/45/15063?source=related_link\">",
"      Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26585?source=related_link\">",
"      Initial surgical management of melanoma of the skin and unusual sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=related_link\">",
"      Interleukin-2 and other immunotherapies for advanced melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=related_link\">",
"      Isotretinoin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=related_link\">",
"      Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=related_link\">",
"      Molecularly targeted therapy for metastatic melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21226?source=related_link\">",
"      Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33447?source=related_link\">",
"      Selection of sunscreen and sun-protective measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=related_link\">",
"      Staging and treatment of Merkel cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14293?source=related_link\">",
"      Systemic treatment of advanced cutaneous squamous and basal cell carcinomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=related_link\">",
"      Treatment and prognosis of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=related_link\">",
"      Treatment and prognosis of cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=related_link\">",
"      Treatment of actinic keratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=related_link\">",
"      Treatment of basal cell carcinomas at high risk for recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42488?source=related_link\">",
"      Tumor node metastasis (TNM) staging system and other prognostic factors in cutaneous melanoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_8_2187="HSANs in newborns";
var content_f2_8_2187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hereditary sensory and autonomic neuropathies that affect newborns",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        HSAN1 (autosomal dominant hereditary sensory radicular neuropathy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HSAN2 (autosomal recessive congenital sensory neuropathy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HSAN3 (Riley-Day syndrome or familial dysautonomia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HSAN4 (congenital insensitivity to pain with anhidrosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital autonomic dysfunction with universal pain loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial amyloid neuropathy (autosomal dominant)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2187=[""].join("\n");
var outline_f2_8_2187=null;
var title_f2_8_2188="Causes of hypothyroidism";
var content_f2_8_2188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of hypothyroidism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic autoimmune thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Iatrogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thyroidectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Radioiodine therapy or external irradiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iodine deficiency or excess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs - thionamides, lithium, amiodarone, interferon-alfa, interleukin-2, perchlorate, tyrosine kinase inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infiltrative diseases - fibrous thyroiditis, hemochromatosis, sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Transient hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Painless (silent, lymphocytic) thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Subacute granulomatous thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Postpartum thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Subtotal thyroidectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Following radioiodine therapy for Graves' hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Following withdrawal of suppressive doses of thyroid hormone in euthyroid patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital thyroid agenesis, dysgenesis, or defects in hormone synthesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Central hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TSH deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TRH deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Generalized thyroid hormone resistance",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2188=[""].join("\n");
var outline_f2_8_2188=null;
var title_f2_8_2189="IPV formulations";
var content_f2_8_2189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Licensed vaccines containing inactivated poliovirus vaccine (IPV) - United States",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Vaccine composition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Trade name",
"      </td>",
"      <td class=\"subtitle1\">",
"       Manufacturer",
"      </td>",
"      <td class=\"subtitle1\">",
"       Approved use in ACIP routine schedule*",
"      </td>",
"      <td class=\"subtitle1\">",
"       Comments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IPV",
"      </td>",
"      <td>",
"       Ipol (Poliovax&Delta;)",
"      </td>",
"      <td>",
"       Sanofi Pasteur",
"      </td>",
"      <td>",
"       2, 4, 6-18 mos, and 4-6 yrs&bull;",
"      </td>",
"      <td>",
"       Approved for use in infants, children, and adults&loz;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DTaP-HepB-IPV&sect;",
"      </td>",
"      <td>",
"       Pediarix",
"      </td>",
"      <td>",
"       GlaxoSmithKline",
"      </td>",
"      <td>",
"       2, 4, and 6 mos",
"      </td>",
"      <td>",
"       Approved for first 3 doses of IPV through age 6 yrs&yen;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DTaP-IPV/Hib&Dagger;",
"      </td>",
"      <td>",
"       Pentacel",
"      </td>",
"      <td>",
"       Sanofi Pasteur",
"      </td>",
"      <td>",
"       2, 4, 6, and 15-18 mos&dagger;",
"      </td>",
"      <td>",
"       Approved for 4 doses of IPV through age 4 yrs**",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       DTaP-IPV&bull;&bull;",
"      </td>",
"      <td>",
"       Kinrix",
"      </td>",
"      <td>",
"       GlaxoSmithKline",
"      </td>",
"      <td>",
"       4-6 yrs",
"      </td>",
"      <td>",
"       Approved for booster dose at age 4-6 yrs&Delta;&Delta;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Advisory Committee on Immunization Practices. Full schedule available at file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5751a5.htm.",
"     <br>",
"      &bull; In the IPV series the minimum age for dose 1 is 6 weeks. The minimum interval is 4 weeks between dose 1 and 2, and between dose 2 and 3. The minimum interval between dose 3 and 4 is 6 months. Dose 4 should be administered at age &ge;4 years regardless of the number of previous doses. Shorter intervals and earlier start dates lead to lower seroconversion rates; therefore, the minimum age and minimum intervals in the first 6 months of life are recommended only if the recipient is at risk for imminent exposure to circulating poliovirus (eg, during an outbreak or because of travel to an endemic region).",
"      <br>",
"       &Delta; Not currently distributed in the United States.",
"       <br>",
"        &loz; Package insert available at file://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm133479.pdf.",
"        <br>",
"         &sect; Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and inactivated poliovirus vaccine combined.",
"         <br>",
"          &yen; Package insert available at file://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm168055.pdf.",
"          <br>",
"           &Dagger; Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and",
"           <em>",
"            Haemophilus",
"           </em>",
"           b conjugate (tetanus toxoid conjugate) vaccine.",
"           <br>",
"            &dagger; When Pentacel is used to provide 4 doses at ages 2,4,6 and 15-18 months, and additional booster dose of age-appropriate IPV containing vaccine (Ipol or Kinrix) should be administered at age 4-6 years. This will results in a 5-dose IPV series; Pentacel is not indicated for the booster dose at age 4-6 years. The minimum interval between dose 4 and dose 5 should be at least 6 months to optimize booster response.",
"            <br>",
"             ** Package insert available at file://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm109810.pdf.",
"             <br>",
"              &bull;&bull; Diphtheria and tetanus toxoids and acellular pertussis adsorbed, and inactivated poliovirus vaccine.",
"              <br>",
"               &Delta;&Delta;Package insert available at file://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm107220.pdf.",
"              </br>",
"             </br>",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination. MMWR Morb Mortal Wkly Re 2009; 58(30):829-830.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2189=[""].join("\n");
var outline_f2_8_2189=null;
var title_f2_8_2190="APRV";
var content_f2_8_2190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Airway pressure release ventilation (APRV)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 293px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Seymour, CW, Frazer M, Reilly, PM, Fuchs, BD. Airway pressure release and biphasic intermittent positive airway pressure ventilation: are they ready for prime time? J Trauma 2007; 62:1298.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2190=[""].join("\n");
var outline_f2_8_2190=null;
var title_f2_8_2191="IVP renal pelvic tumor";
var content_f2_8_2191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    IVP with papillary tumor of the renal pelvis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intravenous pyelogram (IVP) demonstrating filling defects in the renal pelvis (arrows), characteristic of papillary tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Machele Donat, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_8_2191=[""].join("\n");
var outline_f2_8_2191=null;
